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Chapter 1: General Overview 
The overall aim of this thesis was to increase the understanding of distress in people 
living with Motor Neurone Disease (plwMND). Effective medical treatments for Motor Neurone 
Disease (MND) do not currently exist and treatment tends to focus on enhancing quality of life 
by managing physical symptoms. However, there is a limited understanding of the factors that 
are associated with emotional distress and quality of life in MND. Minimal investigation has 
been conducted into the psychological processes underlying distress and the potential utility of 
psychological interventions to alleviate distress in plwMND, despite recognition of the potential 
value of psychological support for plwMND. Increased understanding of the psychological 
processes underlying distress in plwMND will help to guide the development of evidence-based, 
MND-specific psychological interventions to reduce distress and improve quality of life.  
The first question this thesis attempts to answer is: what is the current evidence for 
clinical, demographic, social, and psychological predictors of distress in MND? Chapter 2 
systematically reviews current evidence for prospective predictors of distress in MND. Predictors 
are grouped into clinical and demographic, social, and psychological factors. There are few 
psychologists working with plwMND, thus by considering a variety of predictors, rather than 
psychological factors alone, it was hoped that the paper would attract the interest of a range of 
professionals involved in the care of plwMND. It was anticipated that this would raise awareness 
of distress in plwMND and the value of considering wider factors in supporting people to live 
well with MND. Current evidence is summarised, along with the strengths and limitations of 
both the studies included and the review itself. Findings indicated that there were limited 
prospective studies considering predictors of distress. Of the 11 included studies, there was very 
limited evidence that demographic, clinical, social, or psychological factors predicted distress. 
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There was scarce evidence that any demographic factors predicted distress. There was no 
evidence that overall physical functioning or bulbar functioning predicted distress, but there was 
some mixed evidence for specific clinical factors. For social factors there was consistent 
evidence that lower social support predicted distress. In single studies of psychological 
predictors, mindfulness and cognitive appraisals were significant predictors and warrant further 
investigation. Recommendations for future research are provided, with more studies, with longer 
follow-up periods, and larger sample sizes required to consider conflicting findings and to further 
understand distress in MND.  
Another question this thesis attempts to answer is: Does the transdiagnostic Self-
Regulatory Executive Functioning (S-REF) model of emotional distress have clinical utility in 
plwMND? The S-REF model is one theory of the psychological processes underlying distress. It 
informs metacognitive therapy (MCT) and proposes that repeated information processing in 
response to thoughts, rather than thought content, leads to distress (Wells & Matthews, 1994). 
This processing is termed the cognitive attentional syndrome (CAS; Wells & Matthews, 1994). 
Selection of the CAS is guided by beliefs about thinking, metacognitive beliefs, which can be 
categorised into positive and negative beliefs (Wells & Matthews, 1994). Holding these 
metacognitive beliefs can result in increased attention to thinking, and therefore lead to the CAS 
which results in distress (Wells, 2009).  
There were a number of reasons for testing the S-REF model in plwMND. Firstly, MCT 
is a transdiagnostic and time-limited therapy, which could address a variety of mental health 
difficulties efficiently (Wells, 2013). This is a key consideration for people with a terminal 
condition whereby time is valuable. The S-REF model also posits that it is the process rather 
than the content of thinking that maintains distress, in contrast to traditional cognitive 
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behavioural therapy (Wells & Matthews, 1994). Therefore, MCT could be more suited to 
plwMND as the content of thoughts is often accurate and reflective of the nature of the disease, 
and therefore difficult to challenge. Finally, the S-REF model has demonstrated utility in other 
physical health populations (e.g. Maher-Edwards, Fernie, Murphy, Nikcevic & Spada, 2012; 
Cook et al., 2015; Brown & Fernie, 2015), therefore, the S-REF model warrants exploration in 
plwMND.  
Chapter 3 leads into the empirical paper, which provides a detailed account of a research 
study which aims to test the S-REF model in plwMND. The relationship between metacognitive 
beliefs and distress was assessed, with the mediational role of the CAS considered. 
Metacognitive beliefs were measured by the Metacognitions Questionnaire (MCQ-30; Wells & 
Cartwright-Hatton, 2004), the CAS was assessed by the Repetitive Thinking Questionnaire 
(RTQ-10; McEvoy, Thibodeau, & Asmundson, 2014), and distress was measured by the Hospital 
Anxiety and Depression Scale total score (HADS-T; Zigmond & Snaith, 1983), adapted for 
plwMND. These measures were selected to give a general overview of the model, and its 
applicability to plwMND rather than focusing specifically on a type of distress such as 
depression, or anxiety; or aspect of the CAS such as worry or rumination. This allowed 
consideration of the relationship between metacognitive beliefs and distress, and whether 
metacognitive beliefs influence distress via the theorised pathway by activating the CAS. 
Findings indicated that the key prediction of the S-REF model was supported; the relationship 
between negative metacognitive beliefs and distress was mediated by repetitive negative 
thinking. Findings and implications are described in Chapter 3. The research is discussed in the 
context of previous research, methodological limitations, and directions for future research. 
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It is planned that both chapters of the thesis will be submitted to the journal of Social 
Science & Medicine subject to the author guidelines in Appendix A.   
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Chapter 2: A Systematic Review of the Predictors of Distress in Motor Neurone Disease 
Abstract 
Understanding of the factors that predict emotional distress in Motor Neurone Disease (MND) is 
limited. This systematic review aimed to appraise currently available data to understand the 
clinical and demographic, social, and psychological factors that predict distress over time. A 
systematic search was conducted in three online databases (Medline, PsychINFO and CINAHL 
Plus) up to November 2016. Studies were included if they were prospective studies assessing if 
clinical and demographic, psychological, or social factors at baseline predicted distress at follow-
up at least one month later in adults with a diagnosis of MND. Only studies written in the 
English language, using validated measures of distress or quality of life psychological subscales 
were included. The methodological quality of the articles was also assessed. In total 11 studies 
were included. Demographic or clinical factors were investigated in all 11 studies, social factors 
in two studies, and psychological factors in three studies. No conclusive predictors were 
identified due to the limited number of studies assessing the same predictors, and null or 
contradictory findings. There was scarce evidence that baseline demographic factors predicted 
distress. For clinical factors, there was minimal evidence that percutaneous endoscopic 
gastrostomy use reduced distress. For social factors, there was consistent evidence that lower 
social support predicted increased distress. Psychological factors were considered only in 
individual studies, not allowing for comparison of findings. Cognitive appraisals of coping 
potential, mindfulness, and psychological quality of life were predictors in single studies 
indicating a need for further research. Findings support previous research that there is no simple 
or consistent relationship between physical factors and distress. Findings also highlight the lack 
of prospective research considering potential predictors of distress in MND. Further research is 
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needed to investigate the mechanisms underlying distress, particularly modifiable factors such as 
psychological factors, to reduce distress in people living with MND.  
Review Registration Number: PROSPERO ID:CRD42017050036 
Keywords: Motor Neurone Disease, Amyotrophic Lateral Sclerosis, Psychology, Distress, 
Predictors, Social, Demographic, Clinical 
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Introduction 
Motor Neurone Disease (MND) is a neurological disorder which leads to the progressive 
degeneration and death of motor neurones (Brooks, Miller, Swash & Munsat, 2000). There are 
different variants of MND, including Amyotrophic Lateral Sclerosis (ALS), which can cause a 
range of physical symptoms (Talbot, 2009). This progressive muscular weakness has a variety of 
physical consequences that can affect limb, bulbar, and respiratory muscle (Hobson, Harwood, 
McDermott & Shaw, 2016). This can result in paralysis, swallowing difficulties, speech 
difficulties, and breathing difficulties (Brooks et al., 2000). Cognitive and behavioural changes 
occur in some cases, specifically alterations in social cognition and executive functioning 
difficulties (Bora, 2017). An estimated 10-15% of people living with MND (plwMND) meet the 
diagnostic criteria for frontotemporal dementia (Gordon et al., 2011; Lillo, Mioshi, Zoing, 
Kiernan & Hodges, 2011). MND affects slightly more males than females (ratio 1.5:1; Goldstein 
& Leigh, 1999) and usually occurs sporadically, although there is a familial vulnerability in 5-
10% of cases (Leigh & Ray-Chaudhuri, 1994). MND has a prevalence rate of 7 per 100,000, 
with the average age of onset being 65 years, however, younger (10% under 45 years) and older 
(20% over 70 years) onset are observed (Talbot, 2009). A cure has not been identified and the 
life expectancy for approximately 50% of plwMND is three years from symptom onset (Ilse et 
al., 2015), although 5-10% survive for 10 years or more (Chiò et al., 2013). Riluzole is the only 
treatment option available; a medication that increases survival time by 2-4 months (Lacomblez, 
Bensimon, Leigh, Guillet & Meninger,1996; Miller, Mitchell, Lyon & Moore, 2012). Given the 
limited treatment options, intervention currently focuses on symptom management and 
improving quality of life (QoL; Van den Berg et al., 2005). While the key components of QoL 
are generally agreed to include physical, psychological, spiritual, and social factors, QoL is a 
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complex concept with no universal definition (van Groenestijn, Kruitwagen-van Reenen, Visser-
Meily, Van den Berg & Schroder, 2016) and the factors can vary in importance according to an 
individual’s values (Ferrans, 1990). 
There is increasing recognition that plwMND experience clinically significant 
psychological distress (Felgoise et al., 2010). Distress levels in plwMND are comparable to those 
living with other motor conditions (Taylor, Wicks, Leigh & Goldstein, 2010), and to psychiatric 
outpatients (Felgoise et al., 2010). Distress is more prevalent in plwMND than in healthy 
controls; 20.8% of plwMND compared with 6% of healthy controls were depressed and 85.7% 
compared with 24% were anxious (Cui et al., 2015). Distress in this population has a number of 
negative consequences including increased interest in hastened death (Ganzini, Johnston, 
McFarland, Tolle & Lee, 1998), reduced QoL (Johnston et al., 1999), and reduced survival rates 
(McDonald, Wiedenfeld, Hillel, Carpenter & Walter, 1994). Therefore, interventions to reduce 
distress should be a key priority within the treatment goal of improving QoL in plwMND 
(Pagnini, Simmons, Corbo & Molinari, 2012).  
Given the physical nature of MND, research to date has primarily focused on clinical 
factors. However, an exclusive medical focus is insufficient to provide full support for plwMND 
(Matuz, Birbaumer, Hautzinger & Kübler, 2010) given the multifactorial nature of QoL and 
limited treatments available (van Groenestijn et al., 2016). Furthermore, a simple or consistent 
relationship between physical functioning and distress does not exist (McLeod & Clarke, 2007), 
with growing evidence that psychological QoL remains stable despite disease progression (Cupp 
et al., 2011; Ilse et al., 2015). Physical treatment alone neglects other aspects of QoL; 
accordingly, research has begun to explore other factors associated with distress. Religiosity and 
social support are associated with improved QoL (Cupp et al., 2011; Matuz et al., 2010). 
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Conversely, social withdrawal is associated with depression (Gibbons et al., 2013). 
Psychological factors are also associated with distress, including negative, threatening, and fixed 
illness perceptions, for example; “MND has serious consequences on my life,” or “MND is 
largely due to my own behaviour,” (Matuz et al., 2010; Miglioretti, Mazzini, Oggioni, Testa & 
Monaco, 2008; Plahuta et al., 2002). Furthermore, repetitive negative thinking about the past, or 
rumination, is associated with depression (Hecht et al., 2002).  
Despite increased research into factors beyond clinical predictors, distress in MND 
remains poorly understood and there are no effective psychological or pharmacological 
treatments for distress in this population (Gould et al., 2015). The majority of studies consider 
the prevalence of distress or clinical factors, or are cross-sectional. In order to identify those at 
risk of becoming distressed and highlight targets for intervention, it is important to explore other 
potential contributors to distress, including demographic factors, psychological processes, and 
social factors. Cross-sectional studies identifying correlates of distress are, however, of limited 
value in identifying potential causal factors. For this, prospective research is more informative. 
However, prospective research identifying factors that predict distress over time is yet to be 
synthesised. This systematic review aims to appraise currently available data to understand the 
clinical and demographic, social, and psychological factors that predict distress over time. The 
present review will outline the review methodology, then summarise and critically appraise the 
research findings concerning the predictors of distress. A discussion of the main findings will be 
summarised and concluded with recommendations regarding future research and clinical 
practice. 
EMOTIONAL DISTRESS AND PSYCHOLOGICAL PROCESSES IN MND  
 
12 
Method 
The methodology used in this review broadly followed the PRISMA statement for 
conducting and reporting systematic reviews (Moher, Liberati, Tetzlaff & Altman, 2009). 
Search Strategy 
A review of the literature was conducted to identify published, prospective studies of 
adults with a diagnosis of MND that measured predictors of distress over time using a validated 
measure. Three electronic databases were used to identify relevant articles: Medline (1946 - 
November 2016), PsychINFO (EBSCOhost; 1806 - November 2016), and CINAHL Plus 
(EBSCOhost; 1937 – November 2016). Key words used included “Amyotrophic Lateral 
Sclerosis,” “Motor Neurone Disease,” “Motor Neuron Disease,” “Progressive Muscular 
Atrophy,” “Primary Lateral Sclerosis,” “Progressive Bulbar Palsy,” “Lou Gehrigs Disease,” and 
descriptors or potential predictors of distress including “Depress*,” “Anxiety,” “Distress,” 
“Worry,” “Ruminat*,” “Emotion*,” “Psych*,” “Mood,” “Affect*,” “Psychosocial,” “Coping,” 
“Adapt*,” “Quality of life,” “Adjustment,” “Illness cognition*,” “Fear*,” or “Belief*.” 
Thesaurus and MeSH terms were utilised for specific databases. Full details of the search 
strategy can be found in the protocol (PROSPERO ID:CRD42017050036; see Appendix B). 
Searches were limited to those published in the English language with no restrictions on the date. 
A second reviewer repeated the searches on 30th November 2016. Reference lists of included 
studies were examined and experts in the field were contacted to identify additional relevant 
studies. 
Inclusion Criteria 
Studies eligible for inclusion met the following criteria: a) adults aged 18 years or older; 
b) participants with a diagnosis of MND; c) written in the English language; d) included a 
EMOTIONAL DISTRESS AND PSYCHOLOGICAL PROCESSES IN MND  
 
13 
validated measure of distress or subscale of a QoL measure relevant to distress; e) measured 
associated clinical, demographic, psychological, or social factors; f) prospective studies 
assessing if factors at baseline predict distress at follow-up; g) minimum follow-up duration of 
one month. 
Data Extraction 
Duplicate articles were removed using EndNote X7 software. Study titles and, where 
necessary, abstracts of all papers identified by the search were screened according to the 
inclusion criteria using a screening and selection tool (see Appendix B). Full-text articles of 
remaining studies were obtained and screened according to the same criteria. A second reviewer 
independently screened a random subset of the articles (25%), any discrepancies were resolved 
by consensus. Data from eligible studies was extracted using a standardised protocol (see 
Appendix C). A second reviewer reviewed a random subset of the extracted data (25%).  
Assessment of Risk of Bias 
The risk of bias in the included studies was independently assessed at the study level by 
the author and a second reviewer using a tool adapted from the Agency for Healthcare Research 
and Quality (Williams, Plassman, Burke, Holsinger & Benjamin, 2010). This tool proposes nine 
areas of potential bias that enables the included studies to be compared across these dimensions 
(see Appendix D). Discrepancies in reviewer ratings were resolved through discussion with a 
third reviewer. Studies were not excluded based on the results of the quality assessment, in line 
with guidance from the Centre for Reviews and Dissemination (Centre for Reviews and 
Dissemination, 2009).  
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Data Synthesis 
A meta-analytic review was inappropriate due to the heterogeneity of included studies 
with respect to time since diagnosis, predictors, and distress outcomes assessed. Therefore, a 
narrative synthesis is provided. Findings for each type of distress outcome (anxiety or depression 
case, anxiety or depression severity, emotional distress severity, QoL psychological subscale) are 
discussed within three broad categories of predictor variable: clinical and demographic, social, 
and psychological. 
Results 
Figure 1 outlines the search results and article selection process. The search yielded 1,924 
results, with a total of 1,499 unique articles after removing duplicates. Of these articles, 1,337 
were excluded based on title and abstract. Full-text articles for the remaining 162 records were 
accessed, with 151 excluded, resulting in 11 papers included in the systematic review.  
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Figure 1. Article selection flow chart based upon PRISMA guidelines by Moher, D., 
Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic 
reviews and meta-analyses: The PRISMA statement. Journal of Clinical Epidemiology, 
10(62), 1006-1012. doi:10.1016/j.jclinepi.2009.06.005  
 
Studies included in 
qualitative synthesis  
(n = 11) 
Full-text articles assessed 
for eligibility  
(n = 162) 
Full-text articles excluded, with 
reasons 
Not uniquely MND (n = 9) 
Inadequate distress measure (n = 32) 
Not a prospective study design  
(n = 72) 
Not looking at predictors of distress 
(n = 26) 
Unavailable in English (n = 1) 
Looking at change over time, not 
predictors of distress (n = 11) 
 
Records excluded 
Not adults living with MND (n = 293) 
Not measuring distress (n = 885) 
Not quantitative studies (n = 159) 
Records screened  
(n = 1,499) 
Records identified through 
databases 
MEDLINE (n = 1,061) 
CINAHL Plus (n = 301) 
PsychINFO (n = 520) 
Total (n = 1,882) 
Additional records identified through other 
sources 
Reference lists of included studies (n = 40) 
Additional articles identified by expert (n = 2) 
 
Records after duplicates removed  
(n = 1,499) 
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Table 1 describes study sample characteristics, Table 2 summarises quality assessment 
outcomes, and Table 3 provides a glossary of measures used to assess distress. Finally, Table 4 
summarises study design and findings, grouped by type of distress outcome. 
 The majority of studies (eight studies, 72.73%) were conducted in Europe, with a further 
three studies conducted in America (27.27%). One study limited analyses to those commencing 
non-invasive ventilation (NIV) with orthopnoea symptoms (Bourke, Bullock, Williams, Shaw & 
Gibson, 2003), while another study limited time since diagnosis to less than 15 months 
(Goldstein, Atkins, Landau, Brown & Leigh, 2006). Mean sample ages ranged from 55 to 63 
years.  
 Several measures were used to assess distress; most studies reported distress through 
psychological subscales from QoL measures (five studies). Three studies reported depression 
severity and two papers reported depression caseness. Two studies used distress measures 
designed for plwMND. Overall emotional distress was the primary outcome in one study. Only 
one study also reported the severity of anxiety in addition to depression. No papers reported on 
anxiety alone. Self-report measures were used to assess outcomes of interest across clinical and 
demographic, social, and psychological factors. Two studies used physical measurements 
including forced vital capacity and muscle scores. 
Nine studies utilised multivariate analyses of predictors using regression analysis, although 
there was considerable variation in the method of entry and order of included predictors. Two 
studies utilised modelling methods and one study did not conduct inferential statistics. Nine 
papers used p < 0.05 and one study used p < 0.01 to indicate a significant association.  
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Table 1 
Sample characteristics of included papers 
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Bourke et al., (2003) Time points variable 
according to when met 
criteria for NIV. 
 
Baseline = 22 
T1 = 21 
Met criteria = 17 
Accepted trial = 15 
Continued trial = 10 
- - - 54.54% Recent diagnosis 
group = 
15.2 ± 9.9 (O) 
Referred with 
RMW group= 
54.0 ± 35.0 (O) 
Before NIV = 
32.6 ± 29.0 (O) 
NR Recent diagnosis 
group = 
33.33%  
Referred with 
RMW group = 
28.57%  
Before NIV = 
29.4% 
Recent diagnosis 
group = 
57.8 (32-74) 
Referred with 
RMW group = 
59.3 (48-73) 
Before NIV = 
61.8 (48-74) 
UK 
Cupp et al., (2011) 
 
72 72 48 - - - - 33.33% 37 ± 44 (O) 24% 40% 55 ± 12 America 
Goldstein et al., (2006) 
 
50 32 26 - - - - 48.00% 28.79 ± 17.21 (O) 
9.24 ± 4.26 (D) 
28% 82% 63.14 ± 10.33 UK 
Hillemacher et al., (2004) 
 
41 31 - - - - - 24.39% 24.0 ±  25.8 (D) NR 34.15% 59.9 ± 11.4 Germany 
Lyall et al., (2001) NIV group  
16    16     10      7       4       3      2 
Control group   
11    11      6       4         4       -       - 
 
NIV 
87.5% 
Control
100% 
NR NR 11.11% NIV group =  
61.3 ± 6.8 
Control group = 
61.2 ± 7.6 
UK 
Matuz, Birbaumer, 
Hautsinger & Kübler (2015) 
 
27 22 19 16 - - - 40.75% NR 7.4% 44% 55.3 ± 11.1 Germany 
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McElhiney, Rabkin, Gordon, 
Goetz & Mitsumoto (2009) 
223 113 65 - - - - 70.85% Fatigue group = 
33 ± 28 (O) 
Depression group 
= 33 ± 25 (O) 
Fatigue & 
depression group 
= 35 ± 31 (O) 
Neither group = 
37 ± 31 (O) 
Fatigue group = 
15% 
Depression 
group = 50% 
Fatigue & 
depression 
group = 12% 
Neither group = 
25% 
44% 61 ± 12 America 
Norquist, Jenkinson, 
Fitzpatrick, Swash & ALS-
HPS steering group (2003) 
 
918 439 123 - - - - 86.66% 1.29 ±  1.77 (D) NR 42.16% 59.97 ± 11.54 UK 
multi-
country 
Pagnini, Phillips, Bozma, 
Reece & Langer (2015) 
197 102 - - - - - 48.22% 1-8m 40.1% 
9-16m 24.1% 
17-28m 24.6% 
≥29m 11.7% 
NR 41.1% 58 ± 9.9 Italy 
Roach, Averill, Segerstrom 
& Kasarskis (2009) 
 
55 NR      NR 11.76 ±  20.16 
(D) 
NR 36% 58.4 ± 11.5 America 
Rodriguez de Rivera et al., 
(2011) 
 
42 
 
NR      NR NR 33% 28.57% 57.97 ± 4.56 Spain 
Note. NIV = non-invasive ventilation; NR = not clearly reported; RMW = respiratory muscular weakness.   
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Risk of Bias Assessment 
The results from the assessment of the risk of bias are presented in Table 2. The most 
common methodological limitations were related to the selection of participants, assessment of 
distress and other predictors, justification for sample size, management of missing data, length of 
the follow-up period, and controlling for potential confounders. The majority of studies selected 
participants appropriately, however, two studies lacked detail about how participants were 
recruited. Many studies did not adequately describe the measures used to assess distress and 
other predictors, often not reporting appropriate reliability, internal consistency, or validity 
statistics. The majority of studies measured distress using subscales from larger QoL measures, 
rather than utilising specifically validated measures. This was also the case for some physical 
functioning measures with individual items or subgroups of items used, which were not clearly 
validated for use in this way.  
Sample size was not justified in any of the included studies, resulting in a lack of clarity 
about whether the studies have sufficient power to draw conclusions about the results reported. 
This results in increased potential for inflated Type I error rate. Missing data is expected given 
the terminal nature of MND, however, a number of studies failed to discuss attrition rates, or 
account for missing data in the analysis. Subgroups of participants were often analysed due to 
missing data, which could result in a biased sample. For example, those with shortness of breath 
when lying down, defined as orthopnoea, or those attending repeated assessments. Similarly, 
many studies had follow-up periods that were shorter than Williams et al.’s (2010) suggested 12 
month period, which makes it difficult to conclude that predictors are reliable over time. Some 
studies failed to control for potential confounding variables in analyses, despite reporting these 
when describing the sample. 
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Table 2 
Quality assessment of included papers using adapted tool from William et al., (2010) 
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Bourke et al., (2003) Partially  Unclear Partially Partially  Partially Partially Yes Yes Unclear 
Cupp et al., (2011) Yes  Unclear Partially  Partially  Partially  Partially Partially Partially Yes 
Goldstein et al., (2006) Partially  Unclear Yes Partially Partially  Yes Partially  Partially Yes 
Hillemacher et al., (2004) Yes Unclear Yes Partially Partially Partially Partially Yes Yes 
Lyall et al., (2001) Unclear Unclear Partially Partially Partially Partially Partially Partially Yes 
Matuz et al., (2015) Yes Unclear Yes  Yes  Partially Yes Partially  Partially Yes 
McElhiney et al., (2009) Yes Unclear Yes Partially Partially Partially No Partially  Yes 
Norquist et al., (2003) Yes Unclear Yes Partially  Partially No No Yes Yes 
Pagnini, Phillips et al., (2015) Partially Unclear Partially Partially Partially No Partially Yes Yes 
Roach et al., (2009) Unclear Unclear Partially Yes Yes Yes Yes Yes Yes 
Rodriguez de Rivera et al., 
(2011) 
Partially  Unclear Yes Partially Partially Yes No No Partially 
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A variety of predictors were considered across the studies included in the review. Of the 
11 included studies, 10 considered at least one clinical or demographic predictor, two considered 
social predictors, and three considered psychological predictors of distress. 
Demographic and Clinical Predictors  
Age, gender, and education level. Age was a significant predictor of distress in two out 
of six studies. Younger age predicted worse mental health (Norquist et al., 2003) however, this 
effect was not sustained at an 8 month follow up (Norquist et al., 2003). Younger age predicted 
increased anxiety (Pagnini, Phillips et al., 2015). The two studies that found significant effects 
had larger sample sizes than studies that did not find a significant effect, although both studies 
were limited by relatively short follow up periods of up to eight months compared with the other 
studies considering age as a predictor of distress.  
Gender predicted distress in one of the five studies, with males reporting greater 
psychological wellbeing than females (Roach et al., 2009). This study managed missing data 
well, but was limited by a relatively small sample size for multilevel modelling and lack of 
clarity in reporting of attrition rates, therefore results may be due to inflated Type I error. Only 
one study examined education level and found it did not predict distress (Pagnini, Phillips et al., 
2015).  
Clinical characteristics. Physical functioning was considered in five studies, using a 
variety of physical and self-report measures. In five studies overall physical functioning did not 
predict distress. This appears to be a relatively robust finding over a number of studies. For 
specific aspects of physical functioning, bulbar functioning did not predict distress (Goldstein et 
al., 2006), QoL (Bourke et al., 2003), or depression (Hillemacher et al., 2004) in three studies. 
The methodological strengths and limitation of these studies varied, two studies had good length  
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Table 3 
Glossary of distress measures (DVs) used in included papers 
 
Note. Kübler A., Winter S., Kaiser J., Birbaumer N., Hautzinger M. (2005). Das ALS-Depressionsinventar (ADI): 
Ein Fragebogen zur Messung von Depression bei degenerativen neurologischen Erkrankungen (amyotrophe 
Lateralsklerose). Zeitschrift Fur Klinische Psychologie Und Psychotherapie, 34(1), 19-26. doi:10.1026/1616-
3443.34.1.19 
Simmons, Z., Felgoise, S. H., Bremer, B. A., Walsh, S. M., Hufford, D. J., Bromberg, M. B., … McCluskey, L. 
(2006). The ALSSQOL: Balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology, 
67(9), 1659-1664. doi:10.1212/01.wnl.0000242887.79115.19 
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. 
Archives of General Psychiatry, 4, 561-571. 
Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression scale. Acta Psychiatrica 
Scandinavica, 67(6), 361-370. doi:10.1111/j.1600-0447.1983.tb09716.x 
Spitzer, R. L., Kroenke, K., Williams, J. B. W. (1999). Validation and utility of a self-report version of PRIME-MD: 
The PHQ Primary Care Study. Journal of the American Medical Association, 282(18), 1737–1744. 
doi:10.1001/jama.282.18.1737 
Ware, J. E. & Sherbourne, C. D. (1992). The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual 
framework and item selection. Medical Care, 30, 473-83.  
Von Zerssen, D., & Koeller, D. M. (1976). Paranoid-Depressivitäts-Skala und Depressivitäts-Skala: Manual. Beltz 
Test: Weinheim. 
Cohen, S. R., Mount, B. M., Strobel, M. G., & Bui, F. (1995). The McGill Quality of Life Questionnaire: A measure 
of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. 
Palliative Medicine, 9(3), 207-219. 
 
 
Measure Abbreviation  Outcome assessed 
ALS Depression Inventory ADI-12 Depression 
ALS Specific Quality of Life 
Instrument-Revised 
 
ALSQoL-R Quality of life, Negative emotion scale (NES) 
Beck’s Depression Inventory BDI Depression 
Hospital Anxiety and Depression 
Scale 
 
HADS 
 
Depression (HADS-D, Anxiety (HADS-A), 
Distress (HADS-T) 
Patient Health Questionnaire PHQ-9 Depression 
Short Form-36 SF-36 Quality of life (Mental Health (MH), Mental 
component summary score (MCS)) 
 
Depression Score of von Zerssen 
 
D-S Depression  
The McGill Quality of Life 
Questionnaire 
MQoL Quality of life, psychological wellbeing domain 
(PWB) 
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of follow up (Goldstein et al., 2006; Bourke et al., 2003), yet one of these studies analysed only 
people with respiratory muscular weakness (Bourke et al., 2003). The study by Hillemacher et al. 
(2004) recruited an unbiased sample but was limited by length of follow up and sample size. 
When considered in single studies limb functioning did not predict depression (Hillemacher et 
al., 2004); spinal functioning did not predict distress (Goldstein et al., 2006); and muscular 
scores, partial pressure of carbon dioxide, and maximum inspiratory pressure did not predict 
psychological QoL (Bourke et al., 2003). Although swallowing and breathing impairment did 
independently predict higher depression scores as examined in one study (Hillemacher et al., 
2004). However, this study had a relatively small sample and utilised single items from larger 
measures of physical functioning to determine these effects.  
Three studies assessed the site of symptom onset, categorised as bulbar or non-bulbar 
(spinal or limb). Findings were mixed; higher percentages of depression caseness were reported 
in the bulbar group, followed by the lower limb, and upper limb onset groups (Rodriguez de 
Rivera et al., 2011). This study recruited regular clinic attenders only which led to a strength in 
length of follow up, but may have resulted in a biased sample. Furthermore, inferential statistics 
were not utilised and therefore confounders were not controlled for. Conversely, non-bulbar site 
of onset predicted depression caseness in one study but this effect was accounted for by fatigue 
(McElhiney et al., 2009). The third study found that site of onset was not a predictor of negative 
emotion (Cupp et al., 2011). Studies that did not find an association between site of onset and 
distress had larger samples, although the length of follow up was shorter. One study with a large 
sample size and relatively adequate follow up period found that fatigue predicted depression 
caseness (McElhiney et al., 2009).  
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Table 4 
Summary of study design and significant findings from included papers grouped by outcome (DV) 
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DV - ANXIETY/DEPRESSION CASE 
McElhiney et al., 
(2009) 
223 3 PHQ-9 
(major/ 
minor/ 
absent) 
Stepwise and 
multinomial 
regression 
Fatigue, physical 
functioning, FVC, 
progression rate, 
site of onset 
(Bulbar/ non-
bulbar) 
- - Fatigue (β=0.073) 
Non-bulbar onset (β=-
1.41) (accounted for by 
fatigue) 
Rodriguez de 
Rivera et al., 
(2011) 
42 3 BDI >21 Descriptive  Site of onset 
(Bulbar/Upper 
Limb/Lower Limb) 
  Bulbar = 78.57%, 
Upper Limb = 35.71%, 
Lower Limb= 64.28% 
DV ANXIETY/DEPRESSION 
Hillemacher et al., 
(2004) 
41 6 D-S Logistic  
regression 
Physical 
functioning (total, 
limb, bulbar, 
swallowing, 
breathing), time 
since diagnosis, 
age, gender 
- - Swallowing impairment 
(r = -0.453) (Odds ratio 
(OR) = 0.36; 95% CI 
0.14-0.96),  
Breathing impairment 
(Odds ratio (OR) = 
0.39; 95% CI 0.16-0.96) 
Matuz et al., (2015) 27 3-6 ADI-12 Multiple 
regression  
- Berlin Social 
Support Scales 
Perceived 
social support 
 
Cognitive 
appraisal (coping 
potential), 
MND coping 
scale  
T2: R2=55% 
Perceived social support 
(β = -0.44) 
Appraisal of coping 
potential (β = -0.57) 
         
EMOTIONAL DISTRESS AND PSYCHOLOGICAL PROCESSES IN MND  
 
25 
A
rt
ic
le
 
S
a
m
p
le
 s
iz
e 
 
T
2
, 
T
3
, 
T
4
, 
T
5
, 
T
6
 
(n
 m
o
n
th
s 
la
te
r)
 
D
ep
en
d
a
n
t 
V
a
ri
a
b
le
 (
D
V
) 
A
n
a
ly
si
s 
C
li
n
ic
a
l 
/d
em
o
g
ra
p
h
ic
 
 S
o
ci
a
l 
 P
sy
ch
o
lo
g
ic
a
l 
 S
ig
n
if
ic
a
n
t 
F
in
d
in
g
s 
(p
 <
.0
5
) 
 
Pagnini, Phillips et 
al., (2015) 
 
197 
 
4 
 
HADS-A 
 
 
 
 
HADS-D 
 
Mixed-
effects 
models  
 
Age, gender,  years 
of education, time 
since diagnosis 
 
- 
 
Mindfulness, 
McGill Quality of 
Life Scale 
 
Mindfulness (b = -0.12, 
t(187) = -6.83) 
Age  
(b = -0.73, t(187) = -
3.21) 
 
Mindfulness  
(b = -0.14, t(187) = -
8.20) 
DV – QUALITY OF LIFE PSYCHOLOGICAL SUBSCALE 
Bourke et al., 
(2003) 
22 2  SF-36 
(MCS) 
Efficacy 
Analysis, 
Multivariate 
analysis 
 
NIV, age, gender, 
NIV compliance, 
physical 
functioning (P1 
max, PaCO2, limb 
and axial muscle 
scores, bulbar 
score) 
- - NIV (effect size > 0.8) 
NIV compliance 
predicts duration of 
benefit on MCS (only p 
value reported) 
 
Cupp et al., (2011) 72 3 ALSQoL-
R (NES) 
fraction 
of 
baseline 
Linear 
regression 
(fraction of 
baseline)  
 
Visit number, PEG 
antidepressant use, 
NIV, time between 
intervention and 
scoring, age, site of 
onset (Bulbar/ Non-
bulbar) 
- - Antidepressant 
PEG 
(only p values reported) 
Lyall et al., (2001) 27 1 wk, 
1, 6, 9, 
12, 15 
SF-36 
(MH) 
Repeated 
Measures 
ANOVA  
NIV 
 
- - NS 
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Norquist et al., 
(2003) 
918 4 SF-36 
(MCS) 
 
 
 
Stepwise 
regression 
Physical 
functioning, age, 
gender, time since 
onset, time since 
diagnosis 
 
- SF-36 MCS 
baseline  
T2 R2 = 49.8%, Age (β 
= -.0133), MCS 
baseline (β = 0.682) 
T3 R2 = 53.6%, MCS 
baseline (β = 0.735) 
 
Roach et al., (2009) 
 
55 6 MQoL 
(PWB) 
Multi-level 
modelling,  
Time since 
diagnosis,  
gender, age 
 
- - Gender (male) ϒ = -
1.04 F(1,61) = 3.99 η = 
0.06 
DV – EMOTIONAL DISTRESS 
Goldstein et al., 
(2006) 
50 6 HADS-T Linear 
regression, 
best 
combined 
predictor,  
Physical 
functioning (bulbar, 
spinal), PEG 
Marital 
intimacy, 
social support, 
psycho-social 
impact of 
illness, 
Emotional 
lability, 
executive 
functioning, 
self-esteem, 
cognitive 
dysfunction, 
attention/ 
concentration, 
T2: Negative social 
support at T1 (R2 = 
27%, t = 2.91) 
Note. ANOVA = Analysis of Variance; FVC = forced vital capacity; NIV = non-invasive ventilation; NS = non-significant; P1 max = maximum 
static inspiratory pressure; PaCO2 = partial pressure of carbon dioxide in arterial blood; PEG = percutaneous endoscopic gastrostomy; RMW = 
respiratory muscular weakness; (see Table 3 for details of measures).  
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Time since diagnosis did not predict depression (Hillemacher et al., 2004; Pagnini, 
Phillips et al., 2015), anxiety (Pagnini, Phillips et al., 2015), or mental health (Norquist et al., 
2003; Roach et al., 2009) in four studies. When considered in single studies, time since onset of 
symptoms did not predict mental health (Norquist et al., 2003), progression rate did not predict 
depression caseness (McElhiney et al., 2009), and visit number did not predict mental health 
(Bourke et al., 2003). It appears to be a relatively robust finding over a number of studies that 
time since diagnosis or onset does not influence distress. 
Treatments. Use of non-invasive ventilation (NIV) did not predict mental health in two 
studies with relatively small sample sizes but good length of follow up (Cupp et al., 2011; Lyall 
et al., 2001). However, compliance with NIV treatment did predict the duration of improvement 
in mental health (Bourke et al., 2003). Although this study was limited by a small sample size, 
and demanding two month follow ups may have biased the sample. Of the two papers assessing 
the provision of nutrition via percutaneous endoscopic gastrostomy (PEG), findings were mixed. 
In one study PEG predicted improvement in negative emotions (Cupp et al., 2011). This study 
had a relatively large sample size, and length of follow up period, however was limited by 
management of missing data. In another study PEG did not predict distress (Goldstein et al., 
2006). This study’s strengths were length of follow up period, recruitment of participants close to 
diagnosis, and considering potential reasons for attrition; however, it was limited by a smaller 
sample size.  
Antidepressant medication. Antidepressant use predicted an improvement in negative 
emotion ratings as considered in one study (Cupp et al., 2011).  
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Social Predictors 
Social factors were considered in two of the 11 studies included in the review. Lower 
levels of social support predicted greater overall distress (Goldstein et al., 2006) and depression 
(Matuz et al., 2015). Neither the psychosocial impact of illness nor physical and interpersonal 
marital intimacy predicted distress in one study (Goldstein et al., 2006). These studies were 
relatively robust with both studies demonstrating good follow up periods, although the study by 
Matuz et al., (2015) was limited by a relatively small sample size. 
Psychological Predictors 
Psychological factors were considered individually in three studies. Cognitive appraisals 
of coping potential predicted depression (Matuz et al., 2015), in a study with a relatively small 
sample size. Mindfulness predicted depression and anxiety over time, with lower trait 
mindfulness predicting greater depression and anxiety (Pagnini, Phillips et al., 2015). This study 
had a large sample size but was limited by an eight month follow up period. One study found 
that self-esteem, neuropsychological factors (executive functioning, cognitive dysfunction and 
attention) and emotional lability did not predict distress (Goldstein et al., 2006). This study had a 
relatively small sample size, but was unbiased in selection of participants and had an adequate 
follow up period. Coping strategies (emotion management, emotion avoidance and problem 
management) did not predict depression (Matuz et al., 2015). Overall QoL did not predict 
depression (Pagnini, Phillips et al., 2015), although a mental health subscale of QoL did predict 
later mental health (Norquist et al., 2003). These studies had large sample sizes, however were 
limited by the length of follow up.  
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Discussion 
This is the first review to systematically examine, collect, and appraise current data on 
the demographic, clinical, social, and psychological prospective predictors of distress in 
plwMND. Across the 11 studies included in the review, there was very limited evidence that 
demographic, clinical, social, or psychological factors predict distress.  
Narrative synthesis indicated scarce consistent evidence that any baseline demographic 
factors reliably predict longer-term distress after MND diagnosis. This fits with previous 
findings that gender and age in plwMND are not differentially associated with distress 
(Goldstein & Leigh, 1999; Hogg, Goldstein & Leigh, 1994). For clinical factors, evidence was 
mixed. There was no evidence that overall physical functioning or bulbar functioning predicted 
distress. This appears to be a relatively robust finding over a number of studies. However 
specific swallowing and breathing impairments predicted depression in one study. Although this 
study was limited by a relatively small sample size and the use of single items from larger 
measures of physical functioning to assess specific impairments. These findings are consistent 
with previous reviews that have failed to identify a straightforward or consistent role for physical 
factors in distress (McLeod & Clarke, 2007). This highlights a need to consider more specific 
symptoms that may be associated with distress, or perhaps to focus on the cognitive appraisals 
associated with clinical factors which have demonstrated utility in other health conditions 
(Dempster et al., 2012). There was minimal evidence that PEG reduced negative emotions, 
which had equal numbers of null and significant findings across a small number of studies. The 
study that did not find an effect of PEG was limited by a small sample size thus may have lacked 
power to detect an effect. More studies with longer follow-up periods and larger sample sizes are 
required to consider conflicting findings. In single studies fatigue, compliance with NIV 
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intervention, and antidepressant use predicted distress. However, further detailed investigation of 
these factors is required to clarify their role in distress, given that studies were limited by small 
sample size and inadequate length of follow up respectively.  
There were limited studies on social factors. Nonetheless, there was consistent evidence 
that lower social support predicted distress and depression in two studies. These studies were 
relatively robust with both studies demonstrating good follow up periods, although one study 
was limited by a small sample size. The subjective experience and quality of social support 
appears to act as a buffer to distress, fitting with longstanding views about the value of social 
support for plwMND (Hogg et al., 1994; Rabkin, Wagner & Del Bene, 2000). This is consistent 
with the protective role of social support against distress in other neurological conditions (Elliott, 
Charyton, Sprangers, Lu & Moore, 2011; Simpson, Haines, Lekwuwa, Wardle, Crawford, 2006). 
This also fits with cross-sectional studies of plwMND, finding that increased social support was 
associated with better mental health (Chiò et al., 2004). The remaining social factors considered, 
the psychosocial impact of illness, and marital intimacy were assessed only in single studies and 
did not predict distress. Given the limited number of studies, and lack of clarity about the power 
of studies, research to further evaluate the role of social and relational factors would help to 
clarify their role in distress for plwMND.  
There was limited research into psychological predictors of distress over time. Despite 
this, there were some significant predictors identified by single studies with mindfulness, 
cognitive appraisal of potential to cope, and psychological QoL predicting distress over time. 
This is consistent with cross-sectional research relating a variety of cognitive appraisals to 
distress in plwMND (Matuz et al., 2010; Miglioretti et al., 2008). It is impossible to draw 
conclusions from single studies, yet we can consider the quality of the evidence. Studies 
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investigating mindfulness and psychological QoL both had good sample sizes, but were limited 
by length of follow up period (Pagnini, Phillips et al., 2015; Norquist et al., 2003). Whereas 
Matuz et al.’s (2015) study considering cognitive appraisal of coping potential, had a good 
follow up period but was limited by small sample size. However, further investigation of 
psychological predictors and underlying mechanisms required to understand their role in distress 
for plwMND. 
Limitations of Included Studies 
Caution should be taken when interpreting findings. The studies included were limited 
most commonly by a lack of power calculation increasing the risk of Type I error. Many studies 
also failed to control for confounding factors, for example the majority of studies did not 
consider time since diagnosis or onset in the analysis. Even fewer studies considered time since 
diagnosis as part of their inclusion criteria. This fails to consider how distress evolves over time 
and whether different factors influence distress dependent on symptom severity or time since 
onset. In addition, many studies had inadequate follow-up periods, or insufficient numbers of 
participants at later time points to analyse data, with analyses and conclusions often based upon 
earlier time points. This may not provide enough time between assessments to conclude that 
factors predict distress over time. Additionally, despite the co-morbidity between depression and 
anxiety, the majority of studies failed to consider anxiety focussing instead on depression, mental 
health, or distress. This again highlights the neglect of assessment of distress in plwMND, 
particularly distress other than depression, fitting with the view that medical interventions are 
prioritised in MND treatment (Felgoise et al., 2010). Moreover, there was a wide range of 
measures used to assess distress, with psychological subscales of QoL measures often used rather 
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than more specifically designed and validated tools. This could result in studies measuring 
different conceptual ideas, reducing the utility of comparisons between current studies. 
Implications for Future Research 
 The methodological limitations that restrict our understanding of the predictors of distress 
in MND have important implications for future research. Future research should focus on 
increasing the understanding of predictors of distress by conducting adequately powered studies 
with large sample sizes to manage the risk of Type I error. More longitudinal studies are 
required, despite the challenges in this population, to infer causality between baseline level of 
various predictors and subsequent distress. It would also be useful to separate plwMND into 
groups based upon the time since diagnosis and consider differences based upon the severity of 
symptoms or rate of progression. This will provide greater insight into the role of physical 
factors in distress. As distress measures can be influenced by physical functioning, adapted 
MND-specific measures of distress that are validated in an MND population should be utilised 
(Pagnini, Manzoni, Tagliaferri & Gibbons, 2015). This will ensure valid assessment of the 
concept of distress. Distress should be considered more broadly outside of depression alone. 
Structured diagnostic interviews could also be used as a more valid method of ascertaining 
caseness of depression and anxiety should this be appropriate. Data analysis should control for 
potential confounding factors.  
Clinical and demographic predictors have been considered in the largest number of 
studies and have not demonstrated clear predictive value, with the exception of minimal evidence 
for PEG. These factors are generally unmodifiable, particularly given the lack of treatment 
options available in MND. Therefore, a focus on understanding modifiable factors such as 
psychological predictors should be prioritised in future research. Further research should be 
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theory driven and focus on exploring and testing the specific mechanisms underlying 
psychological predictors. This would inform the development of appropriate psychological 
interventions for plwMND. Evaluation of the effectiveness of these interventions would allow 
health services to direct resources into evidence-based therapies to support plwMND to manage 
distress.  
Strengths and Limitations 
This is the first systematic review to consider clinical and demographic, social, and 
psychological predictors of distress in MND. It addresses an important, under-researched area 
and makes the first steps to understanding more about psychological distress in plwMND to 
guide effective intervention. Limited conclusions can be drawn given that many predictors were 
only assessed by one study, and several studies reported null and contradictory findings. Many 
factors require further investigation to replicate preliminary findings from single studies. 
Publication bias should be considered, with significant results more likely to be published than 
non-significant findings. Furthermore, although a comprehensive search strategy was utilised, it 
is possible that relevant research studies were not included in the review. Adaptation of inclusion 
criteria to consider cross-sectional studies could have resulted in a larger number of studies, and 
therefore resulted in firmer, more informative conclusions. A useful direction for future research 
could be to include cross-sectional studies to answer the question: What are the psychological 
factors associated with distress in MND? Inclusion criteria could be amended to select only 
studies that assessed psychological factors, and used specific measures of distress. This would 
provide a more specific understanding of the psychological predictors of distress and lead to 
conclusions that could guide research into the development of psychological theories and 
interventions. Despite these limitations the conclusions drawn from several studies, rather than 
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based upon individual studies, are likely to be robust. This review highlights the need for further 
research into psychological distress in MND. 
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Chapter 3: The role of metacognitive beliefs and processes in distress in people living with 
Motor Neurone Disease 
Abstract 
Emotional distress following a diagnosis of Motor Neurone Disease (MND) is common and 
many people living with MND experience persistent or recurrent distress. This cross-sectional 
study explored, for the first time, the predictions of the Self-Regulatory Executive Functioning 
(S-REF) model. The S-REF model, an information-processing model of distress, specifies that 
metacognitive beliefs and processes play a fundamental role in the development and maintenance 
of emotional distress. This study explored whether metacognitive beliefs would explain 
additional variance in emotional distress after accounting for major demographics, time since 
diagnosis, and physical functioning. The mediational relationships between metacognitive 
beliefs, repetitive negative thinking, and emotional distress as predicted by the S-REF model 
were also explored. Seventy-seven adults with a diagnosis of MND in the United Kingdom 
(recruited from Preston MND Care Centre, The Walton Centre, the MND Association, and MND 
Scotland) completed self-report questionnaire measures assessing distress, physical functioning, 
repetitive negative thinking, and metacognitive beliefs. Correlational analysis, hierarchical linear 
regression, and mediational analysis were used to test experimental hypotheses. Regression 
analysis showed that metacognitive beliefs were associated with distress and explained 
additional variance in distress after controlling for age, gender, time since diagnosis, physical 
functioning, and repetitive negative thinking. The key prediction of the S-REF model was 
supported; the relationship between negative metacognitive beliefs about the uncontrollability 
and danger of worry and distress was partially mediated by repetitive negative thinking. This is 
the first study to demonstrate that metacognitive beliefs and processes contribute to emotional 
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distress beyond demographic variables, the time since diagnosis, and severity of MND 
symptoms. Prospective research is required to test the causal role of metacognitive beliefs in 
emotional distress in people living with MND, as well as testing if metacognitive therapy is 
effective at reducing distress in MND.  
Key words: Motor Neurone Disease, Amyotrophic Lateral Sclerosis, Distress, Psychology, 
Metacognition, Repetitive Negative Thinking 
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Introduction 
Motor Neurone Disease (MND) is a progressive, fatal neurodegenerative disorder 
affecting the motor neurones (Brooks, Miller, Swash & Munsat, 2000). Common symptoms 
include muscular weakness, atrophy, fasciculations, spasticity, and brisk reflexes (Talbot, 2009). 
The cause is unknown and the majority of cases occur sporadically, although there is a familial 
vulnerability in 5-10% of cases (Hobson, Harwood, McDermott & Shaw, 2016). The clinical 
presentation of MND varies depending on the areas affected, for example, bulbar symptoms 
include speech and swallowing difficulties, whereas non-bulbar symptoms include limb 
weakness and falls (Brooks et al., 2000). Cognitive changes can occur, particularly in executive 
functioning and social cognition (Bora, 2017) and approximately 10-15% of plwMND (people 
living with MND) are also diagnosed with co-morbid frontotemporal dementia (Gordon et al., 
2011; Lillo, Mioshi, Zoing, Kiernan & Hodges, 2011). The course of the disease is variable, with 
disease progression resulting in increased paralysis and breathing difficulties, eventually leading 
to respiratory failure and death (Chiò et al., 2013; Goldstein & Leigh, 1999). A cure does not 
exist and the median life expectancy is 2-4 years from onset (Chiò et al., 2009), although 15-20% 
survive beyond 5 years (Talbot, 2009). Riluzole, a glutamate release antagonist, is the only 
treatment available which increases survival time by 2-4 months (Lacomblez, Bensimon, Leigh, 
Guillet & Meninger, 1996; Miller, Mitchell, Lyon & Moore, 2012). The prevalence of MND in 
Europe ranges from 1.1/100,000 to 8.2/100,000 (Chiò et al., 2013). The incidence is highest in 
55-75 year olds (Hobson et al., 2016), although 10% are younger than 45 years, and 20% are 
older than 70 years (Talbot, 2009). MND affects more males than females, with a lifetime risk of 
1 in 350 for males compared with 1 in 472 for females in the United Kingdom (Hobson et al., 
2016).  
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Many plwMND experience psychological distress including hopelessness, anxiety, 
depression, fear of death, phobic anxiety, and somatization (Felgoise et al., 2010; Pagnini, 
Manzoni, Tagliaferri & Gibbons, 2015). The exact prevalence of distress in plwMND remains 
unclear (McLeod & Clarke, 2007). Estimates suggest approximately 50% of plwMND 
experience clinically relevant levels of anxiety and/or depression that warrant intervention 
(Ganzini, Johnston & Silveira, 2002; Kübler, Winter, Ludolph, Hautzinger & Birbaumer, 2005; 
McDonald, Hillel & Wiedenfeld, 1996). Furthermore, distress in plwMND is more common than 
in the general population (Felgoise et al., 2010) and comparable to those living with other motor 
conditions (Taylor, Wicks, Leigh & Goldstein, 2010). Emotional distress in plwMND is 
associated with a poorer quality of life (Johnston et al., 1999), increased interest in hastened 
death (Fang et al., 2008), and elevated suicide risk (Ganzini, Silveira & Johnston, 2002). Given 
limited medical treatment options, MND care currently focuses on improving quality of life 
through management of physical symptoms (Van den Berg et al., 2005). The development of 
psychological treatment offers an additional route to reduce distress and improve quality of life 
for plwMND. 
However, to date, there is no evidenced MND-specific psychological or pharmacological 
therapy for distress (Gould et al., 2015; Kurt, Nijboer, Matuz & Kübler, 2007). Moreover, the 
psychological mechanisms that underlie distress in MND remain poorly understood. Further 
investigation of these mechanisms is required to inform the development of appropriate 
therapeutic interventions (Matuz, Birbaumer, Hautzinger & Kübler, 2010). Some positive 
outcomes have been demonstrated in preliminary studies of traditional cognitive behavioural 
therapy in plwMND (Díaz et al., 2016). However, this therapy is of limited utility in plwMND as 
appraisals may be accurate, and therefore not amenable to challenge (for example: “There’s no 
EMOTIONAL DISTRESS AND PSYCHOLOGICAL PROCESSES IN MND  
 
48 
cure for MND, I’m not going to get better,” or “I can’t control my symptoms”). The Self-
Regulatory Executive Function (S-REF) model (Wells & Matthews, 1994) may offer a more 
suitable framework for understanding the processes underlying distress experienced by 
plwMND. The S-REF model forms the theoretical basis of metacognitive therapy (MCT; Wells 
& Matthews, 1994), proposing that it is not the content of thoughts, but a pattern of responding 
to thoughts that results in psychological distress (Wells, 2009). This pattern of responding is 
termed the “Cognitive Attentional Syndrome” (CAS). The CAS consists of perseverative 
thinking (e.g. worrying, overanalysing), attentional strategies (e.g. monitoring for negative 
thoughts and feelings), and unhelpful coping strategies (e.g. resting excessively, avoidance of 
activities). Continuation of the CAS is fundamental to the development and persistence of 
emotional distress and is guided by metacognitive beliefs that can be categorised into two 
domains: 1) Positive metacognitive beliefs (for example: “Worrying about MND helps me to 
prepare for the future”); and 2) Negative metacognitive beliefs about the uncontrollability and 
danger of worry (for example: “I can’t control my worry about MND;” Wells & Matthews, 
1994). Holding these metacognitive beliefs can result in increased attention to thinking, and 
therefore lead to the CAS which sustains emotional responses and strengthens negative ideas 
(Wells, 2009). Specifically, positive metacognitive beliefs increase the likelihood of selection of 
repetitive negative thinking as a strategy, therefore acting indirectly to increase distress (Wells, 
2009). Negative metacognitive beliefs about the uncontrollability and danger of worry decrease 
the likelihood of disengaging from repetitive negative thinking due to beliefs that thinking 
cannot be controlled, therefore increasing distress (Wells, 2013). These negative metacognitive 
beliefs also act directly to increase distress due to their content (Wells, 2013). MCT thereby aims 
to challenge metacognitive beliefs (Wells, 2009). MCT has effectively reduced levels of distress 
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in people with a variety of mental health difficulties, such as anxiety and depression (Wells, 
2009). 
In a population where there is little understanding of the processes underlying distress 
the S-REF model is a useful theoretical framework to explore in plwMND for a number of 
reasons. Firstly, MCT is a transdiagnostic and time-limited therapy that could address a variety 
of mental health difficulties efficiently (Wells, 2013). This is a key consideration for people with 
a terminal condition. Furthermore, the S-REF model focuses on the process rather than the 
content of thinking, in contrast to traditional cognitive behavioural theory. This could be more 
suited to plwMND as the content of thoughts is often accurate and reflective of the devastating 
nature of the disease. The S-REF model has also demonstrated utility in other physical health 
populations including Parkinson’s disease (Brown & Fernie, 2015), cancer (Cook et al., 2015), 
and chronic fatigue (Maher-Edwards, Fernie, Murphy, Nikcevic & Spada, 2012). Therefore, 
supporting research to consider whether the S-REF model generalises to plwMND. Findings 
from research with plwMND also support exploration of the S-REF model, since repetitive 
negative thinking, a core component of the S-REF model, is a common coping strategy in MND 
that has been associated with depression (Hecht et al., 2002). Therefore, the S-REF model offers 
a potential framework for understanding distress in MND. Consideration of the S-REF model in 
MND will increase understanding of distress in MND, and encourage a clinical focus on 
psychological wellbeing. This study offers a starting point to guide future research and theory 
into the generalisation and adaptation of psychological models to plwMND. The outcome will 
aid the development of clinical interventions to reduce distress, whether this be through further 
testing of the S-REF model or consideration of alternative theoretical approaches.  
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This study aims to consider the contribution of metacognitive beliefs to understanding of 
distress. And to consider the specific predictions of the S-REF model by considering 
metacognitive beliefs and distress in plwMND, specifically the mediational role of repetitive 
negative thinking. It is hypothesised that:  
1) Metacognitive beliefs will make a significant contribution to emotional distress, over 
and above basic demographic and clinical factors. 
2) Positive metacognitive beliefs will cause emotional distress by activating repetitive 
negative thinking, and will not directly cause or maintain distress.  
3) Negative metacognitive beliefs will cause emotional distress both by activating 
repetitive negative thinking and by triggering a direct emotional response due to their negative 
content.  
Method 
Participants 
All participants reported a diagnosis of MND that had been given by a neurologist, and 
demonstrated sufficient English language to complete the questionnaires. They also reported they 
did not have a diagnosis of Frontotemporal Dementia that had been given by a neurologist as this 
can affect emotional responses (Kumfor & Piguet, 2012). A total of 98 participants were 
assessed for eligibility according to these criteria, either verbally or via online questionnaire. 
Participants with a diagnosis of Frontotemporal Dementia were excluded (n = 6). A total of 77 
plwMND were recruited over a seven-month period to complete a set of self-report 
questionnaires on one occasion. Of the 77 participants, 58 took part online. A further 14 
participants, who took part online, withdrew from the study before completing the 
questionnaires, and 1 participant failed to return the questionnaire pack. Two participants did not 
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provide a full date of diagnosis and were not included in the final analysis, resulting in a final 
sample size of 75 (See Appendix E for participant flow). 
Design 
This study used a cross sectional design using both paper-based and online survey 
methods. 
Sample Size 
A power calculation using G*Power (Faul, Erdfelder, Buchner & Lang, 2009) indicated 
that a sample size of 65 would have 80% power to identify an effect size of 0.25, with seven 
predictors at the p < 0.05 significance level (see Appendix F).  
Measures 
Service user consultation was undertaken to ensure that the materials were appropriately 
presented, sensitive, and understandable.  
Demographics questionnaire. A self-report questionnaire was created to collect the 
following data: participant age, gender, date of diagnosis, date of symptom onset, current 
medications, co-morbid health conditions, and if participants required support to complete the 
questionnaires.  
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). The 
HADS is a 14-item self-report scale designed to assess depression and anxiety in a medical 
population. Items are rated on a 4-item Likert scale. The scale can be separated into anxiety 
(HADS-A), depression (HADS-D), or an overall distress score (HADS-T). Meta-regression 
analysis demonstrated that some items from the HADS were related to physical functioning and 
time since symptom onset in plwMND (Pagnini, Manzoni, et al., 2015). Accordingly, the 11-
item adapted HADS for plwMND was utilised in the current study, with three items related to 
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physical rather than emotional wellbeing removed (Gibbons et al., 2011). In an MND population, 
the HADS demonstrates acceptable internal consistency (PSI = 0.86; Gibbons et al., 2011), 
which was maintained in the current study (α = 0.91). Scores range from 0-33, with higher scores 
indicating higher levels of distress. Cut-offs of 7 and 5 for the adapted HADS-A and HADS-D 
respectively are recommended (Gibbons et al., 2011). 
Metacognitions Questionnaire (MCQ-30; Wells & Cartwright-Hatton, 2004). The 
MCQ-30 is a 30-item short form of the Metacognitions Questionnaire (Cartwright-Hatton & 
Wells, 1997). Items are rated on a 4-point Likert scale. The MCQ-30 consists of five subscales of 
positive metacognitive beliefs about worry, negative metacognitive beliefs about the danger and 
uncontrollability of worry, cognitive confidence, need for control, and cognitive self-
consciousness. The subscales demonstrate adequate internal consistency ranging from (α = 0.72-
0.89; Wells & Cartwright-Hatton, 2004). This was maintained in the current study for an MND 
population (α = 0.88). The subscales also exhibit acceptable test-retest reliability and convergent 
validity in a general population (Wells & Cartwright-Hatton, 2004).  
Repetitive Thinking Questionnaire (RTQ-10; McEvoy, Thibodeau, & Asmundson, 
2014). The RTQ-10 is a 10-item self-report measure that assesses repetitive negative thinking, 
consisting of a subset of items from the full RTQ. Items were originally modified from other 
measures including the Penn State Worry Questionnaire (Meyer, Miller, Metzger & Borkovec, 
1990), the Rumination Response Scale (Nolen-Hoeksema & Morrow, 1991), and the Post-Event 
Processing Questionnaire (Rachman, Grüter-Andrew & Shafran, 2000). The RTQ-10 
demonstrates acceptable internal consistency (α ≥ 0.89) and convergent validity through 
significant associations with a range of emotions (McEvoy, Mahoney & Moulds, 2010). 
Acceptable internal consistency was maintained in the current study for an MND population (α = 
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0. 92). The trait version was used in the current study, with participants rating items about their 
general responses when distressed, rather than in relation to a specific event. Each item is rated 
on a 5-point Likert scale. 
Self-administered ALS Functional Rating Scale-Revised (ALSFRS-R; Cedarbaum 
et al., 1999). The ALSFRS-R is a 12-item self-report measure designed to assess physical 
functioning including bulbar, limb, and respiratory function related to activities of daily living 
for plwMND. Each activity is rated on a 4-item Likert scale with well-defined response points 
for each item (range 0-4). The total score ranges from 0-48, with a higher score indicating better 
physical functioning. The scale has satisfactory internal consistency (α = 0.73; Cedarbaum et al., 
1999), which was maintained in the current study (α = 0.87). It is widely used, and has been 
validated for online administration (Maier et al., 2012). 
Ethical Considerations 
Ethical approval was obtained from the Liverpool Central Health Research Authority 
research and ethics committee (16/NW/0073). A number of ethical considerations were made in 
the design of the study. Multiple methods of participation were offered, including online and 
paper, to ensure the study was accessible to individuals with varying levels of physical ability. 
Participants could be assisted to complete the questionnaires by either the researcher in clinic or 
another chosen person; this was reflected in the consent form by requiring a witness to confirm 
consent should the person be unable to write. Given the demands of attending clinic, it was 
agreed that plwMND would not be approached by the researcher but asked if they would like to 
speak to the researcher by their clinician. Some questions may have been difficult to respond to 
or causes some distress or worry, thus contact details for support and the researcher were 
provided to link with appropriate services if required. Confidentiality and safe storage of data 
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across multiple sites was managed by assigning unique identification codes and storing consent 
forms separately from questionnaire data in locked storage cupboards, with access only available 
to the research team. The ethical requirements of all host sites were met (See Appendices G, H, I, 
J, K, L, M, N, and O). 
Procedure 
All participants provided informed consent for their data to be used for research purposes. 
Participants were presented with an information sheet (see Appendix P), followed by a consent 
form (see Appendix Q), and finally the questionnaire measures detailed above in a random order 
to prevent order effects (see Appendix R). For online data collection, the order of questionnaires 
was automatically randomised using Qualtrics software. For paper data collection 
www.randomizer.org was used to generate the order of measure presentation. 
Participants were identified through multiple sources. PlwMND were invited to 
participate in the study by a clinician during visits with posters placed in clinics to advertise the 
study at The Walton Centre (a specialist neurology and neurosurgery NHS trust) and Preston 
MND Care Centre, UK. Participants were recruited from branch meetings of the Motor Neurone 
Disease Association (MND Association), a UK charity for plwMND. The study was advertised 
online and via social media by the MND Association and MND Scotland, a Scottish charity for 
plwMND. Participants could complete the study online, in a clinic, or at home. A variety of 
participation methods were offered to increase accessibility and therefore maximise the range of 
individuals who could participate. Participants chose whether to complete measures alone, with 
researcher support, or with support from another trusted person. 
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Statistical Analysis 
Statistical analysis was conducted using the Statistical Package for Social Sciences (SPSS 
version 22). Data was deemed to be missing at random, with one missing value from the MCQ-
30 managed using mean imputation (Raymond, 1986) which has demonstrated superiority in 
estimating parameters (Dodeen, 2003). Pair-wise deletion was implemented for two participants 
who did not provide a date of diagnosis. P values of < 0.05 were used to indicate significance. 
First, a preliminary correlational analysis was reviewed to consider relationships between 
distress and metacognitive beliefs generally as they had not yet been explored before in this 
population and different type of metacognitive beliefs can be more important in different groups 
(Wells, 2013). Mann-Whitney U tests explored if there were gender differences between the 
study variables. A hierarchical linear regression analysis tested the first hypothesis that 
metacognitive beliefs would explain additional variance in distress over and above basic 
demographic and clinical factors, as measured by the adapted HADS-T. This analysis controlled 
for major demographic variables, physical functioning, and repetitive negative thinking. 
Predictor variables were entered in the following order: step 1; age, gender, step 2; time since 
diagnosis, physical functioning, step 3; repetitive negative thinking, step 4; metacognitive beliefs 
(all subscales). 
To test the second and third hypotheses that repetitive negative thinking would mediate 
the hypothesised relationship between metacognitive beliefs (positive metacognitive beliefs and 
negative metacognitive beliefs about the danger and uncontrollability of worry) and distress 
(adapted HADS-T) two mediational analyses were conducted. Age, gender, physical functioning, 
and time since diagnosis were controlled for in both analyses. A custom dialog was installed 
using the Hayes (2013) PROCESS macro to conduct mediational analyses (Hayes, 2013). 
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Bootstrapped, bias-corrected, and accelerated (BCa) estimates, and 95% confidence intervals are 
reported for the indirect effect. BCa estimates adjust for potential bias and skew in the bootstrap 
distribution to produce more reliable parameter estimation (Preacher & Hayes, 2004, 2008). 
Following Preacher and Hayes (2004, 2008) recommendation, 5,000 bootstrap samples were 
used in mediation and regression analyses. 
Results 
Participant ages ranged from 29 to 86, with a median of 61.0 (IQR = 54.00 - 68.50). 
There were 42 males (54.50%). Two participants were receiving nutrition via percutaneous 
endoscopic gastrostomy. Two required intubation or tracheotomy, sixteen required non-invasive 
ventilation: eight during the day and night, six during the night only, and two intermittently. The 
median ALSFRS-R score was 30 (IQR = 22.50 - 38.00). Time since diagnosis ranged from 1 to 
258 months. Of the sample, 22.10% met the criteria for severe depression and 19.48% for severe 
anxiety (scores of 8 and above on adapted HADS-D and 9 and above on adapted HADS-A 
respectively; Gibbons et al., 2011). There were 37 participants treated with Riluzole and 27 were 
prescribed an antidepressant, however it was unclear whether this was to treat depression or to 
manage symptoms of MND such as hypersalivation through its side effects.  
Non-parametric tests were used to assess bivariate correlations (see Appendix S for 
exploration of assumptions). The medians, interquartile ranges, and Spearman’s rho correlations 
between distress scores, repetitive negative thinking scores, and metacognitive beliefs are 
presented in Table 1. There were significant positive correlations with distress for negative 
metacognitive beliefs about the uncontrollability and danger of worry, cognitive confidence, 
cognitive self-consciousness, and repetitive negative thinking from 0.26 to 0.69. Repetitive 
negative thinking was also significantly positively correlated with the majority of the MCQ 
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subscales, apart from cognitive confidence. Age significantly correlated with cognitive 
confidence (r = 0.28). As expected time since diagnosis significantly negatively correlated with 
ALSFRS-R score (r = -0.36). There was a significant effect of gender on cognitive confidence, 
with males (Mdn = 9.50) scoring higher than females (Mdn = 7.00), U = 524.50, z = -2.20, p = 
0.03, r = -0.25.  
Association of Metacognitive Beliefs and Distress 
Results of the regression analyses are shown in Table 2. There was no evidence of 
multicollinearity; variance inflation factors were all less than 10, tolerance statistics were greater  
Table 1 
Descriptive statistics and Spearman’s rho correlations between study variables  
 2 3 4 5 6 7 Mdn IQR 
i) HADS-T 0.69*** 0.14 0.68*** 0.26* 0.06 0.36** 9.00 5.00-14.00 
ii) RTQ-10 - 0.37** 0.75*** 0.19 0.24* 0.49*** 24.00 16.00-33.00 
iii) MCQ-PB  - 0.31** 0.14 0.29* 0.28* 7.00 6.00-11.00 
iv) MCQ-NB   - 0.12 0.21 0.57*** 10.00 6.50-14.00 
v) MCQ-CC    - 0.26* 0.01 8.00 6.00-11.00 
vi) MCQ-NC     - 0.36** 9.00 8.00-12.00 
vii) MCQ-CSC      - 14.00 11.00-16.50 
Note. HADS-T = total adapted Hospital Anxiety and Depression scale score; RTQ-10 = repetitive 
thinking questionnaire; MCQ-PB = metacognitions questionnaire positive beliefs about worry subscale; 
MCQ-NB = metacognitions questionnaire negative beliefs about the uncontrollability and danger of 
worry subscale; MCQ-CC = metacognitions questionnaire cognitive confidence subscale;, MCQ-NC = 
metacognitions questionnaire need for control subscale; MCQ-CSC = metacognitions questionnaire 
cognitive self-consciousness subscale.   
* p < 0.05, ** p < 0.01, *** p < 0.001. 
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Table 2 
Statistics for the final regression model predicting distress (adapted HADS-T)  
Variable  ∆R2 ∆F p b 95% BCa CIs β P 
Step 1 
 
 
Constant 
Age 
Gender 
0.08 
 
0.30 
 
0.74  
11.53 
-0.04 
0.59 
 
2.25, 19.24 
-0.16, 0.08 
-2.43, 3.86 
 
 
-0.07 
0.05 
 
 
0.03 
0.55 
0.70 
Step 2  
Constant 
Age 
Gender 
ALSFRS-R 
Time since dx 
0.03 1.01 0.63  
15.03 
-0.05 
0.60 
-0.11 
-0.01 
 
5.10, 23.20 
-0.17, -0.75 
-2.46, 3.81 
-0.28, 0.05 
-0.03, 0.03 
 
 
-0.08 
0.05 
-0.17 
-0.01 
 
0.01 
0.51 
0.70 
0.18 
0.97 
Step 3  
Constant 
Age 
Gender 
ALSFRS-R 
Time since dx 
RTQ-10 
0.43 
 
56.24 <0.001  
-4.55 
0.04 
2.12 
-0.06 
<-0.01 
0.43 
 
-14.61, 4.73 
-0.06, 0.14 
-0.22, 4.33 
-0.17 0.04 
-0.02, 0.02 
0.29, 0.57 
 
 
0.06 
0.16 
-0.09 
-0.01 
0.69 
 
0.37 
0.49 
0.08 
0.93 
0.33 
<0.001 
 
Step 4 
 
 
 
Constant 
Age 
Gender 
ALSFRS-R 
Time since dx 
RTQ-10 
MCQ-PB 
MCQ-NB  
MCQ-CC  
MCQ-NC 
MCQ-CSC 
0.12 
 
3.72 <0.001  
-0.43 
0.02 
1.27 
-0.04 
<0.01 
0.30 
-0.33 
0.55 
0.11 
-0.35 
0.06 
 
-10.97, 8.96 
-0.08, 0.13 
-0.93, 3.28 
-0.16, 0.07 
-0.02, 0.03 
0.12, 0.50 
-0.64, 0.03 
0.14, 0.92 
-0.26, 0.61  
-0.69, 0.14 
-0.29, 0.32 
 
 
0.25 
0.97 
-0.07 
0.02 
0.48 
-0.20 
0.38 
0.06 
-0.17 
0.04 
 
0.93 
0.78 
0.27 
0.43 
0.85 
<0.001 
0.03 
<0.01 
0.54 
0.06 
0.70 
 
Adjusted R2 = 0.59 
Note. ALSFRS-R = Amyotrophic Lateral Sclerosis functional rating scale-revised; dx = diagnosis, RTQ-
10 = repetitive thinking questionnaire; MCQ-PB = metacognitions questionnaire positive beliefs about 
worry subscale; MCQ-NB = metacognitions questionnaire negative beliefs about the uncontrollability and 
danger of worry subscale; MCQ-CC = metacognitions questionnaire cognitive confidence subscale; 
MCQ-NC = metacognitions questionnaire need for control subscale; MCQ-CSC = metacognitions 
questionnaire cognitive self-consciousness subscale. 
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than 0.2, and correlations between the study variables were less than 0.8. There was no evidence 
of autocorrelation as indicated by a Durbin-Watson test statistic of 2.18. There were no outliers 
outside of 3 standard deviations. After controlling for age and gender, factors associated with 
MND severity explained an additional 3% of the variance in distress in step 2. Repetitive 
negative thinking explained a further 43% of the variance in step 3, and in the final step 
metacognitive beliefs explained a further 12% of the variance in distress. The final model 
accounted for 59% of the variance with repetitive negative thinking, positive beliefs about worry 
and, negative beliefs about the uncontrollability and danger of worry making independent 
contributions to the model. 
Mediation of the Relationship between Metacognitive Beliefs and Distress by Repetitive 
Negative Thinking 
Results of the mediation analyses are shown in Figures 1 and 2. Age, gender, time since 
diagnosis, and physical functioning (ALSFRS-R) were controlled for in both mediation analyses.  
For positive metacognitive beliefs, there was a significant indirect effect (ab = 0.44, BCa 95% 
CIs = 0.19 - 0.81) on distress mediated by repetitive negative thinking, the direct effect remained 
significant. It should be noted that there was a negative relationship between positive 
metacognitive beliefs and distress. For negative metacognitive beliefs about the uncontrollability 
and danger of worry, there was a significant indirect effect (ab = 0.42, BCa 95% CIs = 0.10 - 
0.82), mediated by repetitive negative thinking, on distress. The direct effect remained 
significant indicating partial mediation.  
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Figure 1. Mediation of Positive Metacognitive Beliefs on Distress, via Repetitive 
Negative Thinking 
 
Note. HADS-T = total adapted Hospital Anxiety and Depression scale score; RTQ-10 = 
repetitive thinking questionnaire; MCQ-PB = metacognitions questionnaire positive 
beliefs about worry subscale; 
* p < 0.05, ** p < 0.01, *** p < 0.001, ns = non-significant. 
 
c’ (c) 
Positive 
metacognitive beliefs 
(MCQ-PB) 
Distress (HADS-T) 
Repetitive 
negative thinking 
(RTQ-10) 
 
b = 0.93** b = 0.48*** 
b = -0.32* (b = 0.12, ns)  
a b 
 
 
 
 
 
 
 
 
 
Figure 2. Mediation of Negative Metacognitive Beliefs on Distress, via Repetitive 
Negative Thinking 
Note. HADS-T = total adapted Hospital Anxiety and Depression scale score; RTQ-10 = 
repetitive thinking questionnaire; MCQ-NB = metacognitions questionnaire negative 
beliefs about worry subscale; 
* p < 0.05, ** p < 0.01, *** p < 0.001, ns = non-significant. 
c’ (c) 
Negative 
metacognitive beliefs 
(MCQ-NB) 
Distress (HADS-T) 
Repetitive 
negative thinking 
(RTQ-10) 
b = 1.65*** b = 0.26** 
b = 0.52** (b = 0.95***)  
a b 
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Discussion 
This was the first study to explore the utility of the S-REF model in an MND population. 
After controlling for age, gender, time since diagnosis, physical functioning, and repetitive 
negative thinking, metacognitive beliefs accounted for an additional 12% of the variance in 
distress. In the final model, three variables made independent contributions to distress. In 
descending order of magnitude these were repetitive negative thinking, negative metacognitive 
beliefs about the danger and uncontrollability of worry, and positive metacognitive beliefs about 
worry. In line with the S-REF model, the results indicate that metacognitive beliefs are 
associated with distress in plwMND. 
Mediational analyses largely supported hypothesised relationships between 
metacognitive beliefs, repetitive negative thinking, and distress. The relationship between 
negative metacognitive beliefs about the danger and uncontrollability of worry and distress was 
partially mediated by repetitive negative thinking. This is consistent with the S-REF prediction 
that negative metacognitive beliefs will act, both indirectly via the CAS and directly due to their 
content, to influence distress. The relationship between positive metacognitive beliefs and 
distress was inconsistently mediated by repetitive negative thinking. This fits with the S-REF 
prediction that positive metacognitive beliefs guide the selection of the CAS as a coping strategy 
resulting in distress, and do not directly cause or maintain distress. The negative relationship 
between positive metacognitive beliefs and distress is not clearly understood. It could be 
explained by the nature of positive metacognitive beliefs, whereby the perceived helpfulness of 
thinking about difficulties provides a sense of control and ability to cope in the short-term, 
therefore reducing distress. However, when positive metacognitive beliefs lead to the selection of 
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persistent repetitive negative thinking as a coping strategy this results in distress. Nonetheless, 
this study provides support for the utility of the S-REF model in plwMND. 
These findings are fitting with research testing the S-REF model in mental health 
populations (Wells, 2009, 2013), within the general population (Spada, Mohiyeddini & Wells, 
2008), and other physical health populations (Allott, Wells, Morrison & Walker, 2005; Cook et 
al., 2015; Maher-Edwards et al., 2012) which have found that negative metacognitive beliefs 
were a predominant contributor to explaining distress. It could be hypothesised that the 
relationship between metacognitive beliefs and rumination becomes more toxic for plwMND 
who are often unable to effectively communicate their thoughts, perhaps resulting in increased 
repetitive negative thinking. Results also reflect previous findings that physical functioning, time 
since diagnosis, and demographic factors are unable to consistently or satisfactorily explain 
distress in MND (Cupp et al., 2011; De groot, Post, van Heuveln, Van den berg & Lindeman, 
2007; Gauthier et al., 2007; Matuz, Birbaumer, Hautzinger & Kübler, 2015; McElhiney, Rabkin, 
Gordon, Goetz & Mitsumoto, 2009; Montel, Albertini, Desnuelle & Spitz, 2012; Mustfa et al., 
2006; Pagnini, Phillips, Bosma, Reece & Langer, 2015; Rabkin, Wagner & Del Bene, 2000; 
Rabkin et al., 2005). This is also fitting with research noting the role of cognitions in distress 
(Matuz et al., 2010; Miglioretti, Mazzini, Oggioni, Testa & Monaco, 2008; Plahuta et al., 2002), 
which could be explained by the influence of metacognitive beliefs. It would be useful to 
consider whether the S-REF model is better able to account for distress than traditional cognitive 
models. MCT infers the advantage over traditional cognitive therapy of not requiring the 
individual to engage with the content of negative thoughts related to illness, which has been 
reported as distressing in other physical health populations (Baker et al., 2013). Furthermore, 
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MCT is not limited by reality-testing of potentially accurate thoughts associated with MND such 
as “I’m not going to get better.”  
Limitations  
Although the findings of this study appear to be relatively robust there are a number of 
limitations that must be taken into account. Firstly, the study was cross-sectional and therefore 
causality cannot be assumed. In addition, there remains a large proportion of variance that cannot 
be explained by the model thus additional factors that could contribute to distress should be 
considered. Social factors were not measured in the current study, but have been associated with 
distress in plwMND in previous studies (Goldstein, Atkins, Landau, Brown & Leigh, 2006; 
Matuz et al., 2015). Considering social factors, such as quality of perceived social support, may 
result in a more robust model that is able to account for a larger proportion of the variance. 
Furthermore, the study used self-report measures, which rely on the individual to accurately 
assess each domain they are responding to. These measures are prone to response bias, which 
was not accounted for. Additionally, the RTQ-10 is a relatively short measure of repetitive 
negative thinking, which was selected to minimise the time required to complete the study given 
the prevalence of physical limitations and fatigue in this population. A more detailed measure of 
repetitive negative thinking that considers the CAS more widely may be useful to confirm 
findings in future studies. Furthermore, the site of onset was not recorded or controlled for in the 
analysis, although several studies have failed to demonstrate a relationship between site of onset 
and distress (McElhiney et al., 2009; Mora, Salas, Fajardo, Iváñez & Rodríguez-Santos, 2013; 
Vrijsen et al., 2015). This study utilised a relatively small sample of plwMND, which did not 
contain many individuals who were receiving nutrition via percutaneous endoscopic gastrostomy 
or required assisted ventilation. Scrutiny of the model in a larger sample of plwMND would lead 
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to the inclusion of a broader population and allow for grouping of individuals based upon time 
since diagnosis or site of onset to consider any differences between groups. A larger, more 
representative sample would likely strengthen findings and permit the use of alternative 
statistical methods, such as structural equation modelling, which may further the understanding 
of the utility of the S-REF model in plwMND. However, it should be recognised that recruiting 
and retaining plwMND with severe symptoms in research studies can be challenging given poor 
health and prioritisation of end of life needs (Albert et al., 2005). In terminal illness populations 
staff can fear that research is a further burden, given the MND prognosis and the number of 
professionals already involved in their care, and therefore may be reluctant to offer research 
opportunities (Mody et al., 2008). This contrasts with patient’s perspectives, who often wish to 
advance knowledge and improve care for others whilst providing meaning for their own 
experience (Ross & Cornbleet, 2003). Training for staff to increase awareness of the patient 
perspective on research and to feel comfortable discussing research opportunities in plwMND 
could improve access to this population and therefore the representativeness of MND samples in 
research. 
Clinical Implications 
Clinically, this research increases awareness of the prevalence of distress in plwMND 
and the need to recognise and provide psychological support for plwMND. It also provides 
evidence for further investigation of the utility of MCT in reducing distress for plwMND. In a 
population where there is little understanding of the psychological processes underlying distress, 
this study enhances our knowledge. It provides a stepping stone for further research to support 
plwMND who are experiencing distress. Assessing metacognitive beliefs also offers a potential 
method to identify those at risk of developing distress and provide early intervention. 
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Future Research 
Given the limited knowledge of psychological processes underlying distress in plwMND, 
this study significantly adds to the theoretical understanding of the experience of distress for 
plwMND. Future research to further assess the model could utilise a prospective design to 
consider the role of metacognitive beliefs in the development of distress over time. Consideration 
of MND specific factors, such as the relationship of perceived ability to communicate effectively 
with the level of repetitive negative thinking or the influence of social cognition changes on 
thinking processes, could further the understanding of the S-REF model in this population. This 
could potentially support identification and implementation of support for those at risk of 
developing distress. Case studies could be used to consider the effectiveness of MCT at 
challenging metacognitive beliefs, reducing repetitive negative thinking, and therefore distress 
for plwMND. This would help to understand if theoretical knowledge transfers to clinical 
outcomes for plwMND. This has already been demonstrated in a cancer population, with 
theoretical support for the S-REF model (Cook et al., 2015) supported by clinically significant 
effects of MCT in a case study (McNicol, Salmon, Young & Fisher, 2013), and an ongoing open 
trial of MCT for depression and anxiety to consider its effectiveness at alleviating distress 
(Fisher, 2016). Although for plwMND research is earlier in the research cycle, the current study 
offers significant insight into the knowledge of psychological processes in a relatively 
understudied group and provides direction for future research.  
It would also be useful to compare the S-REF model with other psychological models, 
such as the traditional cognitive model, acceptance and commitment therapy (ACT), and 
mindfulness-based cognitive therapy (MBCT) to consider which of these models is most 
effective at explaining and managing distress in plwMND. MBCT and ACT also emphasise the 
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importance of attentional processes underlying emotional distress. MBCT aims to foster the 
ability to pay attention consciously to the present moment in a non-judgemental manner (Kabat-
Zinn, 1994). MBCT intervention includes learning to return attention back to the anchor of the 
breath or body and away from distressing thoughts (Kabat-Zinn, 1994). Whilst ACT aims to 
create a meaningful life while accepting the pain that comes with it using a variety of 
intervention methods which aim to promote mindfulness, including cognitive diffusion and 
contacting the present moment through use of metaphor (Hayes, Strosahl & Wilson, 2016). Both 
of these therapeutic attentional methods differ from MCT as they involve responding to thoughts 
and therefore lead to continued processing, which is hypothesised to maintain metacognitive 
beliefs and activate the CAS (Fisher & Wells, 2009). MCT attentional exercises would instead 
focus on discontinuing further processing thoughts of thoughts, with the specific goal of 
modifying metacognitive beliefs about the uncontrollability of thinking (Wells, 2009). The 
current study provides evidence for the importance of metacognitive beliefs in maintaining 
distress; therefore MCT would be suggested for plwMND over and above other therapies as 
ACT and MCBT act to maintain the CAS, metacognitive beliefs and therefore distress.  However 
further research to understand and compare these models in plwMND will ensure the best 
treatment efficacy and allow choice in intervention for plwMND who are experiencing distress. 
Future studies should utilise more robust methods than previous therapy trials, which are limited 
by inadequate follow-up, no control for differences between groups, no report of whether 
individuals experienced significant distress, and lack of active control conditions (Gould et al., 
2015). Consistent use of validated measures that are designed to measure distress in plwMND 
will allow comparison of the effectiveness of psychological interventions to develop the best 
therapies for plwMND who are experiencing distress.  
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Appendix A – Author Guidelines for the Journal of Social Science & Medicine  
Social Science & Medicine provides an international and interdisciplinary forum for the dissemination of social 
science research on health. We publish original research articles (both empirical and theoretical), reviews, position 
papers and commentaries on health issues, to inform current research, policy and practice in all areas of common 
interest to social scientists, health practitioners, and policy makers. The journal publishes material relevant to any 
aspect of health and healthcare from a wide range of social science disciplines (anthropology, economics, 
epidemiology, geography, policy, psychology, and sociology), and material relevant to the social sciences from any 
of the professions concerned with physical and mental health, health care, clinical practice, and health policy and the 
organization of healthcare. We encourage material which is of general interest to an international readership. 
 
Journal Policies 
The journal publishes the following types of contribution: 
1) Peer-reviewed original research articles and critical analytical reviews in any area of social science research 
relevant to health and healthcare. These papers may be up to 8000 words including abstract, tables, figures, 
references and (printed) appendices as well as the main text. Papers below this limit are preferred. 
2) Peer-reviewed short communications of findings on topical issues or published articles of between 2000 and 4000 
words. 
3) Submitted or invited commentaries and responses debating, and published alongside, selected articles (please 
select the article type 'Discussion' when submitting a Commentary). 
4) Special Issues bringing together collections of papers on a particular theme, and usually guest edited. 
 
Manuscript: 
• Include keywords 
• All figures (include relevant captions) 
• All tables (including titles, description, footnotes) 
• Ensure all figure and table citations in the text match the files provided 
• Indicate clearly if color should be used for any figures in print 
Graphical Abstracts / Highlights files (where applicable) 
Supplemental files (where applicable) 
Further considerations 
• Manuscript has been 'spell checked' and 'grammar checked' 
• All references mentioned in the Reference List are cited in the text, and vice versa 
• Manuscript does not exceed the word limit 
• All identifying information has been removed from the manuscript, including the file name itself 
• Permission has been obtained for use of copyrighted material from other sources (including the 
Internet) 
• Relevant declarations of interest have been made 
• Journal policies detailed in this guide have been reviewed 
• Referee suggestions and contact details provided, based on journal requirements 
 
References 
There are no strict requirements on reference formatting at submission. References can be in any style or format as 
long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article title, 
year of publication, volume number/book chapter and the pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof 
stage. Note that missing data will be highlighted at proof stage for the author to correct. 
 
Formatting Requirements 
The journal operates a double blind peer review policy. For guidelines on how to prepare your paper to meet these 
criteria please see the attached guidelines. The journal requires that your manuscript is submitted with double 
spacing applied. There are no other strict formatting requirements but all manuscripts must contain the essential 
elements needed to convey your manuscript, for example Abstract, Keywords, Introduction, Materials and Methods, 
Results, Conclusions, Artwork and Tables with Captions. 
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If your article includes any Videos and/or other Supplementary material, this should be included in your initial 
submission for peer review purposes. 
Divide the article into clearly defined sections. 
 
Essential cover page information 
The Cover Page should only include the following information: 
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and 
formulae where possible and make clear the article's aim and health relevance. 
• Author names and affiliations in the correct order. Where the family name may be ambiguous 
(e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work 
was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the 
author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the 
country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and 
publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are 
provided in addition to the e-mail address and the complete postal address. Contact details must be kept up 
to date by the corresponding author. 
• Present/permanent address. If an author has moved since the work described in the article was done, or was 
visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. 
The address at which the author actually did the work must be retained as the main, affiliation address. Superscript 
Arabic numerals are used for such footnotes. 
 
Title 
Please consider the title very carefully, as these are often used in information-retrieval systems. Please use a concise 
and informative title (avoiding abbreviations where possible). Make sure that the health or healthcare focus is clear. 
 
Abstract 
An abstract of up to 300 words must be included in the submitted manuscript. An abstract is often presented 
separately from the article, so it must be able to stand alone. It should state briefly and clearly the purpose and 
setting of the research, the principal findings and major conclusions, and the paper's contribution to knowledge. For 
empirical papers the country/countries/locations of the study should be clearly stated, as should the methods and 
nature of the sample, the dates, and a summary of the findings/conclusion. Please note that excessive statistical 
details should be avoided, abbreviations/acronyms used only if essential or firmly established, and that the abstract 
should not be structured into subsections. Any references cited in the abstract must be given in full at the end of the 
abstract. 
 
Keywords 
Up to 8 keywords are entered separately into the online editorial system during submission, and should accurately 
reflect the content of the article. Again abbreviations/acronyms should be used only if essential or firmly 
established. For empirical papers the country/countries/locations of the research should be included. The keywords 
will be used for indexing purposes. 
 
Systematic reviews and meta-analyses must be reported according to PRISMA guidelines. 
 
Footnotes 
There should be no footnotes or endnotes in the manuscript. 
 
Tables 
Please submit tables as editable text and not as images. Tables can be placed either next to the relevant text in the 
article, or on separate page(s) at the end. Number tables consecutively in accordance with their appearance in the 
text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented 
in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules and shading in 
table cells. 
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References 
Citation in text 
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any 
references cited in the abstract must be given in full at the end of the abstract. Unpublished results and personal 
communications are not recommended in the reference list, but may be mentioned in the text. If these references are 
included in the reference list they should follow the standard reference style of the journal (see below) and should 
include a substitution of the publication date with either "Unpublished results" or "Personal communication" 
Citation of a reference as "in press" implies that the item has been accepted for publication. 
 
Web references 
As a minimum, the full URL should be given and the date when the reference was last accessed. Any further 
information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web 
references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be 
included in the reference list. 
 
Data references 
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text 
and including a data reference in your Reference List. Data references should include the following elements: author 
name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] 
immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not 
appear in your published article. 
 
Reference formatting 
There are no strict requirements on reference formatting at submission. References can be in any style or format as 
long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article title, 
year of publication, volume number/book chapter and the pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof 
stage. Note that missing data will be highlighted at proof stage for the author to correct. If you do wish to format the 
references yourself they should be arranged according to the following examples: 
 
Reference style 
Text: All citations in the text should refer to: 
1. Single author: the author's name (without initials, unless there is ambiguity) and the year of publication; 
2. Two authors: both authors' names and the year of publication; 
3. Three or more authors: first author's name followed by 'et al.' and the year of publication. 
Citations may be made directly (or parenthetically). Groups of references should be listed first alphabetically, then 
chronologically. 
Examples: 'as demonstrated (Allan, 2000a, 2000b, 1999; Allan and Jones, 1999). Kramer et al. (2010) have recently 
shown ....' 
List: References should be arranged first alphabetically and then further sorted chronologically if necessary. More 
than one reference from the same author(s) in the same year must be identified by the letters 'a', 'b', 'c', etc., placed 
after the year of publication. 
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Appendix B – Systematic review protocol 
Systematic Review Protocol 
Predictors of distress in Motor Neuron Disease 
Background 
Motor neurone disease (MND) is a neurological disorder which involves the progressive 
degeneration and death of motor neurones. There are a variety of physical consequences 
depending on the neurones affected including progressive muscular weakness and paralysis, 
difficulties with swallowing, speech and breathing (Talbot & Marsden, 2008). Unfortunately no 
cure has yet been identified. Life expectancy for approximately 50% of people diagnosed with 
MND is three years from symptom onset (Ilse et al., 2015). Therefore treatment is focused upon 
symptom management. However, managing physical symptoms alone is insufficient to alleviate 
emotional distress since physical functioning and disease progression are not consistently 
associated with emotional distress (McLeod & Clarke, 2007).  
Other potential contributors to distress need to be explored including demographic 
factors, psychological processes and social factors. This may help to identify those at risk of 
becoming distressed and highlight targets for intervention to reduce emotional distress. To date 
research that considers correlates of distress following diagnosis of MND has not been 
synthesized. Prospective research identifying factors that predict of distress over time, which are 
therefore causally related, is also yet to be synthesized. This systematic review aims to review 
current available data to understand the demographic, social and psychological factors associated 
with distress and also the factors which are predictive of distress over time.  
Review Questions  
 Do any psychological, disease, or social factors predict distress over time in 
MND? 
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Methods 
Search Strategy  
The search strategy will be designed to access published materials. The PROSPERO 
database has been searched to ensure that a similar review is not currently in progress.  
Population  Variable Study Design 
Adults with a diagnosis of 
Motor Neurone Disease. 
 
Studies measuring distress 
with established measures 
(e.g. anxiety, depression, 
hopelessness)  
 
Studies measuring 
associated psychological, 
social or disease factors 
 
Prospective 
 
Electronic databases: 
The following electronic databases will be searched: Medline, PsychINFO (EBSCOhost) 
and CINAHL Plus (EBSCOhost). Searches will be limited to those published in English, human 
adults, with no restrictions on date. The basic search terms are presented below, with searches 
adapted across databases to utilise thesaurus terms. 
Basic search terms:  
Connector Search Terms Search fields 
 “Motor Neuron Disease” OR “Motor Neurone Disease” 
OR “Motor Neurone Diseases” OR “Motor Neuron 
Diseases” OR “Amyotrophic Lateral Sclerosis” OR 
“Progressive Bulbar Palsy” OR “Lou Gehrigs Disease” 
OR “Progressive Muscular Atrophy” OR “Primary 
Lateral Sclerosis” 
All Fields 
AND “Depress*” OR “Anxiety” OR “Distress” OR “Worry” 
OR “Ruminat*” OR “Emotion*” OR “Psych*” OR 
“Mood” OR “Affect*” OR “Psychosocial” OR 
“Coping” OR “Adapt*” OR “Quality of life” OR 
All Fields  
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“Adjustment” OR “Illness cognition*” OR “Fear*” OR 
“Belief*”  
AND NOT “Paediatric*” OR “Child*” OR “infant*” OR 
“Adolescent*” 
Abstract 
AND NOT “Gene*” OR “Mutation*”  Abstract 
AND NOT “Mice” OR “Mouse” OR “Rat*” OR “Animal*” Abstract 
 
Other search strategies 
  Reference lists and bibliographies of the articles collected from those identified will be 
manually searched. Key authors in the area will be contacted to check that relevant studies have 
not been missed.  
Screening and selecting studies to include in the review  
  All references identified by the search will be imported into the EndNote reference 
manager. Duplicate references will be identified and removed using EndNote referencing 
software. Titles and abstracts will be screened for relevance. Full copies of articles identified by 
the search, and considered to meet the inclusion criteria, based on their title, abstract and subject 
descriptors, will be obtained for further consideration. The reviewer will select articles against 
the inclusion criteria using a screening and selection tool (see Appendix). Another reviewer will 
also re-run the search and review a subset of the references for comparison purposes. 
Discrepancies in reviewer selections will be resolved through discussion with a third party and 
comparison with the search inclusion and exclusion criteria. Articles identified through reference 
lists and bibliographic searches will also be considered for data collection based upon their title.  
Reporting results of searches 
  Results of searches will be detailed and documented according to PRISMA guidelines 
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(Moher, Liberati, Tetzlaff, & Altman, 2009). 
Data Extraction  
Data will be extracted from relevant studies including: general study details (author, date, 
country of origin, recruitment method); participant demographics (age, gender, time since 
diagnosis, time since onset of symptoms, onset of symptoms - bulbar or limb); study design and 
methodology (sample size, attrition if prospective studies, correlated factors, analysis method); 
and a summary of the reported findings (reported distress levels, any relevant correlations and/or 
predictors). A subset of the extracted data will also be checked by another reviewer. If required 
data is missing the authors will be contacted to request relevant data. 
Quality Assessment 
Selected studies will be assessed for quality using a tool adapted from Williams et al., 
(2010). This quality assessment will also be completed by another reviewer. Discrepancies in 
reviewer ratings will be resolved through discussion with a third party. 
Data synthesis 
A narrative synthesis of the findings will be presented. Factors that correlate with or 
predict distress will be grouped and findings synthesised within three broad categories of factors: 
demographic or clinical; social; and psychological. If there are sufficient high quality papers 
using established measures of distress a meta-analysis may be conducted. 
Dissemination  
Findings will be submitted to a journal in the field for publication. 
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Appendix  
 
Search Strategies 
 
PsycINFO  
 
 PsychINFO 
Thesaurus terms in italics 
 
 Amyotrophic Lateral Sclerosis OR “Motor Neuron 
Disease” OR “Motor Neurone Disease” OR “Motor 
Neurone Diseases” OR “Motor Neuron Diseases” OR 
“Amyotrophic Lateral Sclerosis” OR “Progressive 
Bulbar Palsy” OR “Lou Gehrigs Disease” OR 
“Progressive Muscular Atrophy” OR “Primary Lateral 
Sclerosis” 
All Fields 
AND Major Depression (explode) OR Depression (emotion) 
OR Rumination (cognitive process) OR Anxiety 
Disorders (explode) OR Emotional Adjustment 
(explode) OR Adjustment (explode) 
Adjustment Disorders OR Coping Behavior OR 
Distress OR Post-Traumatic Stress OR Posttraumatic 
Stress Disorder (explode) OR “Depress*” OR 
“Anxiety” OR “Distress” OR “Worry” OR “Ruminat*” 
OR “Emotion*” OR “Psych*” OR “Mood” OR 
“Affect*” OR “Psychosocial” OR “Coping” OR 
“Adapt*” OR “Quality of life” OR “Adjustment” OR 
“Illness cognition*” OR “Fear*” OR “Belief*” 
 
All Fields 
AND NOT Cells (biology) (explode) 
 
All fields 
 
AND NOT OR “Gene*” OR “Mutation*” Abstract 
AND NOT “Paediatric*” OR “Child*” OR “infant*” OR 
“Adolescent*” 
Abstract 
AND NOT “Mice” OR “Mouse” OR “Rat*” OR “Animal*” Abstract 
 
PsycINFO limiters: 
Publication Type: All Journals; Language: English; Age Groups: Adulthood (18 yrs & older), 
Young Adulthood (18-29 yrs), Thirties (30-39 yrs), Middle Age (40-64 yrs), Aged (65 yrs & 
older), Very Old (85 yrs & older); Population Group: All  
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 (“Motor Neuron Disease” OR “Motor Neurone Disease” OR “Motor Neurone Diseases” OR 
“Motor Neuron Diseases” OR “Amyotrophic Lateral Sclerosis” OR “Progressive Bulbar Palsy” 
OR “Lou Gehrigs Disease” OR “Progressive Muscular Atrophy” OR “Primary Lateral 
Sclerosis”) OR (DE “Amyotrophic Lateral Sclerosis”) 
AND (DE "Major Depression" OR DE "Anaclitic Depression" OR DE "Dysthymic Disorder" 
OR DE "Endogenous Depression" OR DE "Late Life Depression" OR DE "Postpartum 
Depression" OR DE "Reactive Depression" OR DE "Recurrent Depression" OR DE "Treatment 
Resistant Depression" OR DE "Depression (Emotion)" OR DE "Rumination (Cognitive 
Process)" OR DE "Anxiety Disorders" OR DE "Acute Stress Disorder" OR DE "Castration 
Anxiety" OR DE "Death Anxiety" OR DE "Generalized Anxiety Disorder" OR DE "Obsessive 
Compulsive Disorder" OR DE "Panic Disorder" OR DE "Phobias" OR DE "Post-Traumatic 
Stress" OR DE "Posttraumatic Stress Disorder" OR DE "Separation Anxiety Disorder" OR 
(((((DE "Emotional Adjustment" OR DE "Emotional Control" OR DE "Identity Crisis") OR (DE 
"Adjustment" OR DE "Emotional Adjustment" OR DE "Occupational Adjustment" OR DE 
"School Adjustment" OR DE "Social Adjustment")) OR (DE "Adjustment Disorders")) OR (DE 
"Coping Behavior")) OR (DE "Distress")) OR (DE "Post-Traumatic Stress" OR DE 
"Posttraumatic Stress Disorder" OR DE "Complex PTSD" OR DE "DESNOS")  
OR “Depress*” OR “Anxiety” OR “Distress” OR “Worry” OR “Ruminat*” OR “Emotion*” OR 
“Psych*” OR “Mood” OR “Affect*” OR “Psychosocial” OR “Coping” OR “Adapt*” OR 
“Quality of life” OR “Adjustment” OR “Illness cognition*” OR “Fear*” OR “Belief*” 
NOT (AB “Paediatric*” OR “Child*” OR “infant*” OR “Adolescent*”)  
NOT (AB “Gene*” OR “Mutation*”)  
NOT (AB “Mice” OR “Mouse” OR “Rat*” OR “Animal*”)  
NOT ("Cells (Biology)" OR DE "Adipocytes" OR DE "Astrocytes" OR DE "Autophagy" OR 
DE "Blood Cells" OR DE "Cell Membrane" OR DE "Cell Migration" OR DE "Cell Nucleus" 
OR DE "Chromosomes" OR DE "Cones (Eye)" OR DE "Connective Tissue Cells" OR DE 
"Cytoplasm" OR DE "Cytoskeleton" OR DE "Endoplasmic Reticulum" OR DE "Epithelial 
Cells" OR DE "Golgi Apparatus" OR DE "Granule Cells" OR DE "Mast Cells" OR DE 
"Mitochondria" OR DE "Neuroglia" OR DE "Neurons" OR DE "Oligodendrocytes" OR DE 
"Progenitor Cells" OR DE "Ribosomes" OR DE "Sperm" OR DE "Stem Cells") 
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MEDLINE 
 Medline 
Thesaurus terms in italics 
 
 Amyotrophic Lateral Sclerosis [Psychology] (Explode) 
OR Motor Neuron Disease [Psychology] (explode) OR 
Progressive Bulbar Palsy [Psychology] (Explode) OR 
Spinal Muscular Atrophy [Psychology] (Explode) OR 
“Motor Neuron Disease” OR “Motor Neurone 
Disease” OR “Motor Neurone Diseases” OR “Motor 
Neuron Diseases” OR “Amyotrophic Lateral 
Sclerosis” OR “Progressive Bulbar Palsy” OR “Lou 
Gehrigs Disease” OR “Progressive Muscular Atrophy” 
OR “Primary Lateral Sclerosis” 
All Fields 
AND Depression [Psychology & epidemiology] (explode) 
OR Depressive Disorder [Psychology & 
Epidemiology] (explode) OR Affective Symptoms 
[Psychology & epidemiology] (explode) OR Anxiety 
Disorders [Psychology & epidemiology] (explode) OR 
Anxiety [Psychology & epidemiology] (explode) OR 
Metacognition (Explode) OR Thinking (explode) Or 
Psychology (explode) OR Emotions (explode) OR 
Affect (explode) OR Adaptation Psychological 
(Explode) Or Emotional Adjustment (explode) Or 
Quality of Life [psychology] (Explode) OR Fear 
[Psychology] (explode) OR “Depress*” OR “Anxiety” 
OR “Distress” OR “Worry” OR “Ruminat*” OR 
“Emotion*” OR “Psych*” OR “Mood” OR “Affect*” 
OR “Psychosocial” OR “Coping” OR “Adapt*” OR 
“Quality of life” OR “Adjustment” OR “Illness 
cognition*” OR “Fear*” OR “Belief*” 
All Fields 
NOT Biological science disciplines (explode) 
 
All Fields 
AND NOT “Paediatric*” OR “Child*” OR “infant*” OR 
“Adolescent*” 
Abstract 
AND NOT “Gene*” OR “Mutation*”  Abstract 
AND NOT “Mice” OR “Mouse” OR “Rat*” OR “Animal*” Abstract 
 
MEDLINE Limiters:  
Language: English; Humans, female, male; Age group: All adult 
 
((Amyotrophic Lateral Sclerosis or Motor Neuron Disease or Bulbar Palsy, Progressive or 
Muscular Atrophy, Spinal or ('Motor Neuron Disease' or 'Motor Neurone Disease' or 'Motor 
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Neurone Diseases' or 'Motor Neuron Diseases' or 'Amyotrophic Lateral Sclerosis' or 'Progressive 
Bulbar Palsy' or 'Lou Gehrigs Disease' or 'Progressive Muscular Atrophy' or 'Primary Lateral 
Sclerosis')) and (Depressive Disorder or Depression or Affective Symptoms or Anxiety 
Disorders or Anxiety or Metacognition or Thinking or Psychology or Emotions or Affect or 
Adaptation, Psychological or Emotional Adjustment or "Quality of Life" or Fear or ('Depress*' 
or 'Anxiety' or 'Distress' or 'Worry' or 'Ruminat*' or 'Emotion*' or 'Psych*' or 'Mood' or 'Affect*' 
or 'Psychosocial' or 'Coping' or 'Adapt*' or 'Quality of life' or 'Adjustment' or 'Illness cognition*' 
or 'Fear*' or 'Belief*'))).af. not Biological Science Disciplines.ab. not ('Mice' or 'Mouse' or 'Rat*' 
or 'Animal*').ab. not ('Gene*' or 'Mutation*').ab. not ('Paediatric*' or 'Child*' or 'infant*' or 
'Adolescent*').ab. 
 
limit 30 to (english language and male and female and humans and "all adult (19 plus years)") 
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CINAHL 
No thesaurus 
Connector Search Terms Search fields 
 “Motor Neuron Disease” OR “Motor Neurone Disease” 
OR “Motor Neurone Diseases” OR “Motor Neuron 
Diseases” OR “Amyotrophic Lateral Sclerosis” OR 
“Progressive Bulbar Palsy” OR “Lou Gehrigs Disease” 
OR “Progressive Muscular Atrophy” OR “Primary 
Lateral Sclerosis” 
All Fields 
AND “Depress*” OR “Anxiety” OR “Distress” OR “Worry” 
OR “Metacog*” OR “Ruminat*” OR “Emotion*” OR 
“Psych*” OR “Mood” OR “Affect*” OR 
“Psychosocial” OR “Coping” OR “Adapt*” OR 
“Quality of life” OR “Adjustment” OR “Illness 
cognition*” OR “Fear*” OR “Belief*”  
All Fields  
AND NOT “Paediatric*” OR “Child*” OR “infant*” OR 
“Adolescent*” 
Abstract 
AND NOT “Gene*” OR “Mutation*”  Abstract 
AND NOT “Mice” OR “Mouse” OR “Rat*” OR “Animal*” Abstract 
 
CINAHL limiters 
Language: English; Age group: All Adult; Publication Type: All  
 
( "Motor Neuron Disease" OR "Motor Neurone Disease" OR "Motor Neurone Diseases" OR 
"Motor Neuron Diseases" OR "Amyotrophic Lateral Sclerosis" OR "Progressive Bulbar Palsy" 
OR "Lou Gehrigs Disease" OR "Progressive Muscular Atrophy" OR "Primary Lateral Sclerosis" 
) AND ( "Depress*" OR "Anxiety" OR "Distress" OR "Worry" OR "Metacog*" OR "Ruminat*" 
OR "Emotion*" OR "Psych*" OR "Mood" OR "Affect*" OR "Psychosocial" OR "Coping" OR 
"Adapt*" OR "Quality of life" OR "Adjustment" OR "Illness cognition*" OR "Fear*" OR 
"Belief*" ) NOT AB ( "Paediatric*" OR "Child*" OR "infant*" OR "Adolescent*" ) NOT AB ( 
"Gene*" OR "Mutation*" ) NOT AB ( "Mice" OR "Mouse" OR "Rat*" OR "Animal*" )  
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Screening and Selection Tool 
 
Review Questions 
 What are the psychological, social and disease factors associated with distress in Motor 
Neuron Disease? 
 What are the factors identified at diagnosis that predict later distress in Motor 
Neuron Disease? 
Inclusion Criteria 
Population  Variable Study Design 
Adults with a diagnosis of 
Motor Neurone Disease. 
 
Studies measuring distress 
with established measures 
(e.g. anxiety, depression, 
hopelessness)  
 
Studies measuring 
associated psychological, 
social or disease factors 
 
Prospective 
 
Reviewer: Date: 
Author: Year: 
Title: Journal: 
Patient population Include 
Adults with: 
 Motor Neuron Disease 
 Amyotrophic Lateral 
Sclerosis 
 Spinal Muscular Atrophy 
 Primary Lateral Sclerosis 
 Progressive Bulbar Palsy 
 Lou Gehrig’s Disease 
 Progressive Muscular 
Atrophy 
 Machedo Joseph Disease 
 Kennedy’s disease 
 Monomelic Amyotrophy 
Exclude 
 Children 
 Staff 
 Carers 
 Frontotemporal Dementia 
 Sarcopenia 
 Multifocal Motor 
Neuropathy 
 Neuropathy 
 Camptocormia 
 Guillain-Barre syndrome 
 Charcot Marie Tooth 
 Hirayama disease 
 Corticobasal degeneration 
 Progressive Supranuclear 
Palsy 
 Diseases that mimic MND 
 Postpolio syndrome 
 Werdnig-Hoffman disease 
 Other diseases 
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Measures Include 
 Established measures of 
distress (depression, 
anxiety, hopelessness, 
Quality of life measure 
with mental health scale) 
Exclude 
 No measure of distress 
e.g. 
 Biological or genetics 
studies 
 Other therapies 
(physiotherapy, speech 
and language, dietician, 
neuropsychology) 
 Quality of life measure 
without mental health 
scale, or inadequate 
assessment of mental 
health e.g. one question 
only 
 
Study type Include 
 Prospective studies 
 
Exclude 
 Cross-sectional studies 
 Case reports 
 Reviews 
 Personal 
commentaries 
 Legal proceedings 
 Interviews 
 Focus groups 
 Memoriams 
 Obituaries 
 Magazine articles 
Population Include 
 MND only 
 Analysis considers MND 
separately from other 
conditions 
Exclude 
 MND with other 
neurological or 
terminal conditions 
Predictors Include 
Considers predictors of 
distress such as 
 Age 
 Gender 
 Onset of symptoms 
 Date of diagnosis 
 SES 
 Psychological factors 
 Time  
Exclude 
 Does not consider any 
predictors of distress  
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Appendix C – Data extraction sheet 
Data Extraction Sheet 
Form for the extraction of information from primary studies: 
Predictors of distress in MND 
Study 
Author(s): 
Title: 
Date:  
Research Question: 
 
 
Study Sample 
Target population: 
 Country: Ethnicity:  
 Gender: Age: 
 Employment/Educ Status: 
 Diagnosis: Treatment: 
 
Data collection 
Setting:  Home / Clinic / other (specify)  
Method: Interview / Questionnaires 
Outcome Variables Assessed (Measures used): 
 Anxiety  Y/N  
 Depression  Y/N  
 QoL(mental health scale)  Y/N  
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 Other (specify) Y/N  
Adequacy of measures: 
 
Predictor Variables Assessed: 
 Medical  Y/N  
 
 
 Social/environmental Y/N  
 
 
 Psychological Y/N 
Design 
 Prospective cohort  
 Other:  
  
Timing:  Baseline assessment:  
 Follow-up assessments: 
Sampling Method: 
 Entry and exclusion criteria: 
Is sample representative of study population  Y/N 
 
Sample size:  
 Was a prior estimate made for sample size Y/N 
 If yes, what was the power of the study:  
 Baseline response rate: 
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 Follow-up response rate: 
Results 
Were the basic data adequately described? Y/N 
 
Quantitative: 
 Analysis used: 
 Statistical findings reported (list) 
  
 
 Statistical information omitted 
 
Discussion 
Author’s conclusion: 
 
 
Attrition:  not discussed / inadequately treated / treated well 
 
Reviewers comments 
 
 
 
Include / Exclude 
Reason: 
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Appendix D – Quality Assessment Tool adapted from Williams et al. (2010) 
Quality Assessment – Observational Studies (adapted from William et al., 2010) 
 
General instructions: Grade each criterion as “Yes,” “No,” “Partially,” or “Unclear.” 
Factors to consider when making an assessment are listed under each criterion. Note that 
some criteria will only apply to specify types of study.  
 
1) Unbiased selection of the cohort? 
Factors that help reduce selection bias: 
 Prospective study design  
 Inclusion/exclusion criteria 
o Clearly described  
o Diagnosis of MND or ALS reported and by which criteria e.g. El Escorial 
probable or definite, 
 Recruitment strategy 
o Clearly described 
o Relatively free from bias (selection bias might be introduced, e.g., by recruitment 
via advertisement) 
o If a comparison group was used, was the sample and selection appropriate? And 
did the study investigators ensure groups were comparable by matching, etc. 
 
2) Sample size calculated? 
Factors to consider: 
 Did the authors report conducting a power analysis or describe some other basis for 
determining the adequacy of study group sizes for the primary outcome(s) of interest? 
 Did the eventual sample size deviate by < 10% of the sample size suggested by the power 
calculation? (only applicable if power calculation conducted) 
 
3) Adequate description of the cohort? 
Factors to consider:  
 Age 
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 Gender 
 Time since diagnosis / onset of symptoms 
 Site of onset 
 Treatment 
 Physical impairment 
 
4) Validated method for ascertaining distress? 
Factors to consider: 
 Was the method used to ascertain distress clearly described? (Details should be sufficient 
to permit replication in new studies.) 
 Was a valid and reliable measure used to ascertain exposure? (standardised measure, 
Cronbach’s Alpha reported etc, self-report measures tend to have lower reliability and 
validity than clinical interview, single items of scales taken form larger measures are 
likely to lack content validity and reliability) 
 Were these measures implemented consistently across all study participants? 
 
5) Validated method for ascertaining other predictors? 
Factors to consider: 
 Were predictors assessed using valid and reliable measures? (standardised measure, 
Cronbach’s Alpha reported etc, self-report measures tend to have lower reliability and 
validity than clinical interview, single items of scales taken form larger measures are 
likely to lack content validity and reliability) 
 Were these measures implemented consistently across all study participants? 
 
6) Adequate follow-up period? 
Factors to consider: 
 Minimum adequate follow-up period 1 year, shorter follow-up period may be appropriate 
for individuals in advanced stage of disease 
 A justification for the follow period length is preferable 
 Follow-up period should be the same for all groups 
o In cohort studies, length of follow-up should be the same across all groups 
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o OK if differences in follow-up time were adjusted for using statistical techniques, 
e.g., survival analysis. 
 
7) Missing data? 
Factors to consider: 
 Did attrition from any group exceed 30%? (Attrition is measured in relation to the time 
between baseline/allocation and outcome measurement. Where different numbers of 
patients are followed up for different outcomes, use the number followed up for the 
primary outcome for this calculation.) Note criteria of <30% may be unrealistic over 
longer follow-up periods given the nature of MND  
 Did attrition differ between groups by more than 10% percent? 
 If missing data is present and substantial, were steps taken to minimize bias (e.g. 
sensitivity analysis or imputation) 
 
8) Analysis controls for confounding? 
Factors to consider: 
Did the analysis control for any baseline differences between groups? 
 Does the study identify and control for important confounding variables and effect 
modifiers? (Confounding variables are risk factors that are correlated with MND and 
distress and may therefore bias the estimation of the effect of predictors on distress if 
unmeasured. These may include demographic and clinical variables (e.g., using 
demographics or clinical factors likely to be correlated with predictor and outcome) 
 
9) Analytic methods appropriate? 
Factors to consider: 
 Was the kind of analysis done appropriate for the kind of outcome data? 
o Dichotomous – logistic regression, survival 
o Categorical – mixed model for categorical outcomes 
o Continuous – ANCOVA, mixed model 
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 Was the analysis done on an intention-to-treat basis? (That is, was the impact of loss to 
follow-up [or differential loss to follow-up] assessed, e.g., through sensitivity analysis or 
another intent-to-treat adjustment method? 
 Was the number of variables used in the analysis appropriate for the sample size? (The 
statistical techniques used must be appropriate to the data and take into account issues 
such as controlling for small sample size, clustering, rare outcomes, multiple comparison, 
and number of covariates for a given sample size) 
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Appendix E – Participant Flow 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure E1. Flow of participants through the study 
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Appendix F – Power Calculation and sample size 
A power calculation using G*Power (Faul, Erddelfer, Buchner & Lang, 2009) indicated 
that a sample size of 65 would have 80% power to identify an effect size of 0.25, with seven 
predictors at the p < 0.05 significance level. Planned predictors were age, gender, time since 
diagnosis, physical functioning, repetitive negative thinking, positive metacognitive beliefs and 
negative metacognitive beliefs. Although comparable studies have found a large effect size (f2 = 
0.49) (Allot, Wells, Morrison, & Walker, 2005) a conservative estimate of f2 = 0.25 was adopted 
to ensure the study was sufficiently powered to detect an effect.  
 
References 
Allott, R., Wells, A., Morrison, A. P., & Walker, R. (2005). Distress in Parkinson's disease: 
Contributions of disease factors and metacognitive style. The British Journal of 
Psychiatry, 187(2), 182-183. doi:10.1192/bjp.187.2.182 
Faul, F., Erdfelder, E., Buchner, A., & Lang, A. G. (2009). Statistical power analysis using 
G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods, 
41(4), 1149-1160. doi:10.3758/BRM.41.4.1149 
 
EMOTIONAL DISTRESS AND PSYCHOLOGICAL PROCESSES IN MND  
 
102 
Appendix G – Research Review Committee Approval 
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Appendix H – Research Review Committee Amendment Approval 
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Appendix I – Research Review Committee Amendment Approval 
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Appendix J – University of Liverpool Sponsorship Approval 
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Appendix K – Research and Ethics Committee Approval 
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Appendix L – Research and Ethics Committee Approval Amendment Approval 
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Appendix M – Site Permission Letter (Walton Centre) 
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Appendix N – Site Permission Letter (Preston) 
 
EMOTIONAL DISTRESS AND PSYCHOLOGICAL PROCESSES IN MND  
 
113 
 
EMOTIONAL DISTRESS AND PSYCHOLOGICAL PROCESSES IN MND  
 
114 
Appendix O – Health and Research Authority Approval 
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Appendix P – Participant Information Sheet 
 
 
 
Participant Information Sheet– IRAS Ref – 189296 
 
Study Title: Exploring the relationship between beliefs, worry and distress in Motor 
Neurone Disease (MND) 
We would like to invite you to take part in a research study. Before you decide we would like 
you to understand why the research is being done and what it would involve for you. Please take 
some time to read the following information carefully. Ask others what they think about the 
study and perhaps share this information sheet with them if you wish. You can contact the 
researcher with any questions that you may have about the study. Please let us know if there is 
anything that is not clear. 
What is the purpose of the study?  
 
There is very little research about psychological support in MND. This study aims to understand 
some of the factors that may impact on a person’s wellbeing in MND. This includes looking at 
factors such as the role of metacognitive beliefs (our beliefs about our thoughts) and thinking 
patterns. It is hoped that findings from this research will help better guide future research, 
interventions, and support for people with MND. 
 
Why have I been invited?  
 
You have been invited because you have a diagnosis of MND.  
 
Do I have to take part?  
 
No - It is up to you whether you decide to take part. If you decide to take part, you will be asked 
to tick a checkbox on a consent form. If you are unable to do this, it would not prevent you from 
taking part. Instead the person assisting you to complete the study will tick a checkbox to 
confirm that you have consented to take part. You are free to withdraw at any time, without 
giving a reason. If you decide to withdraw from the study, you can have the data you provide 
destroyed up to 48 hours after completing the study. After this point it will not be possible to 
destroy the data, as it will be made anonymous and so we would not be able to identify specific 
participants. If you are currently receiving care, this would not be affected in any way. You will 
not have to respond to any questions you do not wish to. 
 
What will happen to me if I take part and what will I have to do?  
 
You will be asked to complete some questionnaires. This should take no longer than 40 minutes 
and you will only be asked to do this once. You will complete the questionnaires on a computer, 
with or without the support of a person close to you.  
 
What if I have trouble communicating? 
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We understand that some people with MND may have difficulties with writing or speaking. We 
would like to ensure that this would not prevent you from taking part. It is very important that 
the perspectives of people who have difficulties with communicating are represented in the 
study. You can complete the questionnaires with a relative/friend/carer or other person that you 
feel comfortable with.  
 
What are the possible risks of taking part?  
 
There is little risk in taking part in the study. It could be that you find some questions difficult to 
respond to as they may cause some level of upset or worry. You can contact the researcher about 
this (details below), the Motor Neurone Disease Association helpline (0808 802 6262) or 
Samaritans (08457 90 90 90) should you experience any distress following the study.  
 
You can be referred to see a psychologist in your local area for support via any member of your 
local MND team or your GP if you feel this would be helpful. You should contact a member of 
the research team for more local support services should you require them (details below). 
 
What are the possible benefits of taking part?  
 
Although we cannot promise the study will help you directly, the information we collect will 
help us to understand distress in MND and could help to shape psychological treatment for 
people with MND in the future. 
 
What happens when the research study stops? 
 
When you have completed all the study questions, you will not be asked to take any further part 
in the study. 
 
The findings will be written up as part of the researcher’s thesis that will form part of their 
doctoral training to become a clinical psychologist. No confidential information will be used in 
these reports. The researchers hope to publish papers in academic journals and to present the 
findings at conferences. With your consent, the researchers also hope to further analyse your 
anonymous data in future studies, which have been given ethical approval. 
 
How can I access the study findings? 
 
The study will last for about two years. Therefore a summary of the overall findings will not be available 
until after this time period. The summary will be available on the MND Association’s website 
(www.mndassociation.org/research) and on the MND Association’s research blog 
(www.mndresearch.wordpress.com) when the study is complete. Alternatively you can contact 
the researcher to obtain a copy via email, telephone or post using the details at the end of the 
information sheet.  
 
What if there is a problem?  
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If you have a concern about any aspect of this study, you should contact the researchers who will 
do their best to answer your questions. If you remain unhappy or have a complaint which you 
feel you cannot come to the researchers with, then you should contact the Research Governance 
Officer at the University of Liverpool at ethics@liv.ac.uk or on 0151 794 8290. When contacting 
the Research Governance Officer, please provide details of the name or description of the study 
(so that it can be identified), the researchers involved, and the details of the complaint you wish 
to make. 
 
Will my taking part in the study be kept confidential?  
 
No information will be passed onto any other person without your permission. The only 
exception will be if there is a direct risk of harm to you or another person. In these cases it may 
be necessary to talk to another health professional, such as a GP or therapist. If this happens this 
would normally be discussed with you first.  
All information collected about you during the study will be kept strictly confidential, and any 
information about you that has your name and address will be removed so that you cannot be 
recognised. You will not be named or identified in any reports of the study. 
All data collected from the study will be kept safely and securely on a password protected 
computer. Your data will be anonymised and stored securely at the University of Liverpool and 
The Walton Centre. Dr Peter Fisher (supervising this study) will be the custodian of the study 
data. Dr Selina Makin will be responsible for the archiving of data stored at The Walton Centre. 
With your permission, the data will be archived and stored for up to 10 years after the end of this 
study. If you consent, your anonymised data may also be used in future studies that have been 
given ethical approval. 
 
Who is organising and funding the study? 
 
The University of Liverpool have provided the funding for the researcher to carry out this study 
and the University of Liverpool is the study sponsor. 
 
Who has reviewed the study?  
 
This study was given a favourable ethical opinion for conduct in the NHS and other sectors by 
the Doctorate in Clinical Psychology Research Ethics Committee. All research in the NHS is 
looked at by an independent group of people, called a Research Ethics Committee to protect your 
safety, rights, wellbeing and dignity. This study was reviewed and given a favourable ethical 
opinion for conduct in the NHS by The North West Liverpool Central Research Ethics 
Committee (Reference Number: 16/NW/0073). 
 
Who can I contact for further information about this study?  
 
If you have any questions at all, please contact the researcher: 
Miss Rachel Dodd (tel: 0151 794 5102, email: doddr@liv.ac.uk) who is based at the Division of 
Clinical Psychology, Whelan Building, University of Liverpool, Liverpool, L69 3GB. 
 
Alternatively, you may prefer to contact: 
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Dr Peter Fisher (tel: 0151 794 5102, email: plfisher@liverpool.ac.uk) who is based at the 
Division of Clinical Psychology, Whelan Building, University of Liverpool, Liverpool, L69 3GB 
Or Dr Selina Makin (tel: 0151 556 3183, email: selina.makin@thewaltoncentre.nhs.uk) who is 
based at The Walton Centre, Sid Watkins Building, Lower Lane, Liverpool, L9 7LJ. 
 
Thank you very much for taking the time to read this information sheet. 
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Appendix Q – Participant Consent Form 
 
 
Participant Consent Form - IRAS Ref - 189296 
Title of Project: Exploring the relationship between beliefs, worry and distress in Motor 
Neurone Disease (MND) 
Name of Researcher: Rachel Dodd 
  Please initial 
the box  
1 I confirm that I have read and understand the information sheet dated 4th 
April 2016 (Version 7) for the above study. I have had the chance to think 
about the information, ask questions and have my questions answered.  
 
2 I understand that taking part is voluntary and that I can change my mind at 
any time without giving any reason, without my medical care or legal rights 
being affected.  
 
3 I agree to take part in the above study  
 
4 I agree that anonymised data from the study may be used in future studies, 
which have been given ethical approval. 
 
5 I understand that relevant sections of my medical notes and data collected 
from the study may be looked at by regulatory authorities or by persons 
from the Trust where it is relevant to my taking part in this study. I give 
permission for these persons to have access to this information.   
 
 
 
           
Name of participant   Date    Signature 
 
 
 
Name of person taking consent   Date    Signature 
 
If participant is unable to sign: I confirm that I am completing these questionnaires with the participant’s 
permission and under their direction. 
 
 
Name of witness / person assisting  Date    Signature  
with questionnaires 
Version 4 11th February 2016 Consent Form 
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Appendix R – Questionnaire Booklet  
 
 
 
 
Questionnaire Booklet 
Beliefs, worry and distress in MND 
IRAS Ref - 189296 
 
Includes: 
1. Demographic Questionnaire 
2. Self-Administered ALS Functional Rating Scale 
Revised 
3. Metacognitions Questionnaire 
4. Repetitive Thinking Questionnaire 
5. Hospital Anxiety and Depression Scale 
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Demographics Questionnaire 
Please complete the following questions by entering numbers into the 
boxes or circling as appropriate. 
 
1. Age: Years 
 
 
2. Gender (Please Circle):  Male  Female 
 
 
3.  Date of onset of MND symptoms  (This may be difficult 
to pinpoint - your best estimate is fine): 
 
 
Month    Year  
 
4. Date of diagnosis of MND:     
 
 
Month    Year 
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5. Who is completing this questionnaire with you (Please Circle): 
No-one Researcher Family Friend Carer  Other 
If Other Please State……………………………………………………………………… 
 
6. Please list any other health conditions: (continue on the next 
page if required) 
 
 
 
 
 
 
7. Please list any current medications:  (continue on the next page if 
required) 
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SA-ALSFRS-R (Cedarbaum et al., 1999) 
These questions are about how you are currently functioning at home. Please read 
each item carefully and base your answers on your functioning today compared to 
the time before you had any symptoms of Motor Neurone Disease (MND). Please 
choose the answer that best fits your functional status today by placing a tick next 
to your answer. 
 
Compared to the time before you had symptoms 
of Motor Neuron Disease: 
 
1. Have you noticed any changes in your speech? 
 
 No change 
 Noticeable speech differences 
 Speech has changed; often asked to repeat words or phrases 
 Speech has changed; sometimes need the use of alternative 
communicative methods (i.e. computer, writing pad, letter 
board or eye chart) 
 Unable to communicate verbally 
 
2. Have you noticed any changes (increases) in the amount of 
saliva in your mouth (regardless of medication use) 
 
 No change 
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 Slight but definite excess of saliva, with or without night time 
drooling  
 Moderate amounts of excessive saliva, with or without 
minimal day time drooling 
 Marked amount of excessive saliva, with some day time 
drooling 
 Marked excessive saliva with marked drooling requiring a 
constant tissue or handkerchief 
3. Have there been any changes in your ability to swallow? 
 No change (all foods and liquids) 
 Some changes in swallowing or occasional choking episodes 
(including coughing during swallowing)  
 Unable to eat all consistencies of food and have modified 
the consistency of foods eaten 
 Use a feeding tube (PEG) to supplement what is eaten by 
mouth 
 Do not eat anything by mouth and receive all nutrition 
through a feeding tube (PEG) 
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4. Has your handwriting changed? Please choose the best answer 
that describes your handwriting with your dominant (usual) 
hand without a cuff or brace.  
 
 No change 
 Slower and/or sloppier but all the words are legible 
 Not all words are legible 
 Able to grip pen but unable to write 
 Unable to hold pen 
5. The following question refers to your ability to cut foods and 
handle utensils (feed yourself). If PEG, skip to part b. EITHER  
 
5a. Cutting and handling utensils: 
 No change 
 Somewhat slow and clumsy (or different than before), but 
no assistance or adaptive equipment 
 Sometimes need help with cutting more difficult foods 
 Food must be cut by someone else but can feed slowly with 
assistance 
 Need to be fed 
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OR 5b. Using a feeding tube (PEG). 
 Use PEG without assistance or difficulty 
 Use PEG without assistance however may be slow and/or 
clumsy  
 Require assistance with closure and fasteners 
 Provide minimal assistance to caregiver 
 Unable to perform any of the manipulations 
 
6. Has your ability to dress and perform self-care activities (i.e. 
bathing, teeth brushing, shaving, combing your hair, other 
hygienic activities changed?) 
 No change 
 Perform self-care activities without assistance but with 
increased effort or decreased efficiency 
 Require intermittent assistance or use different methods 
(i.e. sit down to get dressed, fasten buttons with a fastener or 
your non-dominant hand) 
 Require daily assistance 
 Do not perform self-care activities and completely 
dependent on caregiver 
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7. Has your ability to turn in bed and adjust the bed clothes (i.e. 
cover yourself with the sheet or blanket) changed? 
 No change 
 Can turn in bed and adjust the bed clothes without 
assistance but it is slower or more clumsy 
 Can turn in bed OR adjust the bed clothes without assistance 
but with great difficulty 
 Can initiate turning in bed or adjusting the bed clothes but 
require assistance to complete the task 
 Helpless in bed 
 
8. Has your ability to walk changed? 
 No change 
 Walking has changed but do not require any assistance or 
devices (i.e. foot brace, stick, walker) 
 Require assistance to walk (i.e. cane, walker, foot brace, 
hand-held assistance) 
 Can move legs or stand up but unable to walk from room to 
room 
 Cannot walk or move my legs 
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9. Has your ability to climb stairs changed? 
 No change 
 Slower 
 Unsteady and need to hold the handrail 
 Require 2 handrails or 1 rail and a stick/person 
 Cannot climb stairs 
 
 
10. Do you experience shortness of breath or have difficulty 
breathing? 
 No change 
 Shortness of breath only with walking 
 Shortness of breath with minimal exertion (i.e. Talking, 
eating, bathing or dressing) 
 Shortness of breath at rest while either sitting or lying down 
 Significant shortness of breath (all of the time) and 
considering using mechanical ventilation  
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11. Do you experience shortness of breath or have difficulty 
breathing while lying down on your back? 
 No change 
 Occasional shortness of breath while lying on back but don’t 
routinely use more than two pillows to sleep 
 Shortness of breath while lying on back and require more 
than two pillows (or an equivalent) to sleep 
 Can only sleep sitting up due to shortness of breath 
 Require the use of respiratory (breathing) support (BiPAP® or 
invasive ventilation via tracheostomy) to sleep and do not sleep 
without it 
12. Do you require respiratory (breathing) support? 
 No respiratory support 
 Intermittent use of BiPAP® 
 Continuous use of BiPAP® at night 
 Continuous use of BiPAP® at night and during the day (Nearly 
24 hours per day) 
 Mechanical ventilation by intubation or tracheotomy 
(BiPAP® is commonly used to describe non-invasive pressure ventilation and 
its use here in no way endorses or promotes a particular product) 
Please ensure that you have responded to all items. Thank you 
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Metacognitions Questionnaire (MCQ) – Sam Cartwright & Adrian Wells. 
This questionnaire is concerned with beliefs people have about their 
thinking. Listed below are a number of beliefs that people have expressed. 
Please read each item and say how much you generally agree with it by 
circling the appropriate number. Please respond to all the items, there are 
no right or wrong answers. 
 
 
Do not 
agree 
Agree 
slightly 
Agree 
moderately 
Agree 
very 
much 
1. Worrying helps me to 
avoid problems in the 
future 
1 2 3 4 
2. My worrying is 
dangerous for me 
1 2 3 4 
3. I think a lot about my 
thoughts 
1 2 3 4 
4. I could make myself 
sick with worrying 
1 2 3 4 
5. I am aware of the way 
my mind works when I 
am thinking through a 
problem 
1 2 3 4 
 
 
EMOTIONAL DISTRESS AND PSYCHOLOGICAL PROCESSES IN MND  
 
133 
 
Do not 
agree 
Agree 
slightly 
Agree 
moderately 
Agree 
very 
much 
6. If I did not control a 
worrying thought, and 
then it happened, it 
would be my fault 
1 2 3 4 
7. I need to worry in 
order to remain 
organized 
1 2 3 4 
8. I have little confidence 
in my memory for words 
and names 
1 2 3 4 
9. My worrying thoughts 
persist, no matter how I 
try to stop them 
1 2 3 4 
10. Worrying helps me to 
get things sorted out in 
my mind 
1 2 3 4 
11. I cannot ignore my 
worrying thoughts 
1 2 3 4 
12. I monitor my 
thoughts 
1 2 3 4 
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Do not 
agree 
Agree 
slightly 
Agree 
moderately 
Agree 
very 
much 
13. I should be in control 
of my thoughts all of the 
time 
1 2 3 4 
14. My memory can 
mislead me at times 
1 2 3 4 
15. My worrying could 
make me go mad 
1 2 3 4 
16. I am constantly aware 
of my thinking 
1 2 3 4 
17. I have a poor memory 1 2 3 4 
18. I pay close attention 
to the way my mind 
works 
1 2 3 4 
19. Worrying helps me 
cope 
1 2 3 4 
20. Not being able to 
control my thoughts is a 
sign of weakness 
1 2 3 4 
21. When I start 
worrying, I cannot stop 
1 2 3 4 
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Do not 
agree 
Agree 
slightly 
Agree 
moderately 
Agree 
very 
much 
22. I will be punished for 
not controlling certain 
thoughts 
1 2 3 4 
23.  Worrying helps me 
to solve problems 
1 2 3 4 
24. I have little 
confidence in my 
memory for places 
1 2 3 4 
25. It is bad to think 
certain thoughts 
1 2 3 4 
26. I do not trust my 
memory 
1 2 3 4 
27. If I could not control 
my thoughts, I would not 
be 
able to function 
1 2 3 4 
28. I need to worry, in 
order to work well 
1 2 3 4 
29. I have little 
confidence in my 
memory for actions 
1 2 3 4 
30. I constantly monitor 
my thoughts 
1 2 3 4 
Please ensure that you have responded to all items. Thank you 
From Wells (1997), with permission. 
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RTQ-10 (Trait) (From McEvoy, Thibodeau & Asmundson, 2015 with 
permission) 
In this questionnaire we are interested in understanding how you 
respond to distressing situations. Please recall how you tend to respond 
when you feel distressed or upset. 
How true (1-5) are each of these statements with respect to your 
experience when you are distressed or upset? 
 Not 
True 
at all 
 Some 
what 
True 
 Very 
True 
1. I have thoughts or images 
about all my shortcomings, 
failings, faults, mistakes.  
1 2 3 4 5 
2. I have thoughts or images 
about events that come into 
my head even when I do not 
wish to think about them 
again 
1 2 3 4 5 
3. I have thoughts or images 
that “I won’t be able to do my 
job/work because I feel so 
badly. ” 
1 2 3 4 5 
4. I have thoughts or images 
that are difficult to forget. 
1 2 3 4 5 
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Not 
True 
at all 
 Some 
what 
True 
 Very 
True 
5. Once I start thinking about 
the situation, I can’t stop. 
1 2 3 4 5 
6. I notice that I think about 
the situation. 
1 2 3 4 5 
7. I have thoughts or images of 
the situation that I try to resist 
thinking about. 
1 2 3 4 5 
8. I think about the situation 
all the time.  
1 2 3 4 5 
9. I know I shouldn’t think 
about the situation, but can’t 
help it. 
1 2 3 4 5 
10. I have thoughts or images 
about the situation and wish it 
would go better. 
1 2 3 4 5 
 
 
Please ensure that you have responded to all items. Thank you 
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Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) 
Clinicians are aware that emotion play and important part in most illnesses. If your 
clinician knows about these feelings he or she will be able to help you more.  
This questionnaire is designed to help your clinician to know about how you feel. Read 
each item below and select the reply which comes closes to how you have been feeling 
in the past week. Don’t take too long over your responses, your immediate reaction to 
each item will probably be more accurate than a thought-out response: 
1. I feel tense or wound up: 
 Most of the time 
 A lot of the time 
 Time to time, occasionally 
 Not at all 
 
2. I still enjoy the things I used 
to enjoy: 
 Definitely as much 
 Not quite so much 
 Only a little 
 Not at all 
 
 
3. I get a sort of frightened 
feeling as if something awful is 
about to happen: 
 Very definitely and quite 
badly 
 Yes, but not too badly 
 A little, but it doesn’t worry 
me 
 Not at all 
 
4. I can laugh and see the funny 
side of things: 
 As much as I always could 
 Not quite so much now 
 Definitely not so much now 
 Not at all 
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5. Worrying thoughts go 
through my mind: 
 A great deal of the time 
 A lot of the time 
 From time to time, but not 
too often 
 Only occasionally 
 
 
6. I feel cheerful 
 Not at all 
 Not often 
 Sometimes 
 Most of the time 
 
7. I can sit at ease and feel 
relaxed: 
 Definitely 
 Usually 
 Not often 
 Not at all 
 
 
 
8. I feel as if I am slowed down: 
 Nearly all of the time 
 Very often 
 Sometimes 
 Not at all 
 
9. I get a sort of frightened 
feeling like ‘butterflies in the 
stomach’: 
 Not at all 
 Occasionally  
 Quite often 
 Very often 
 
10. I have lost interest in my 
appearance: 
 Definitely 
 I don’t take as much care 
as I should 
 I may not take quite as 
much care 
 I take just as much care as 
ever 
Running Head: EMOTIONAL DISTRESS AND PSYCHOLOGICAL PROCESSES 
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11. I feel restless as if I have to 
be on the move: 
 Very much indeed 
 Quite a lot 
 Not very much 
 Not at all 
 
12. I look forward with 
enjoyment to things: 
 As much as I ever did 
 Rather less than I used to 
 Definitely less than I used 
to 
 Hardly at all 
13. I get sudden feelings of 
panic 
 Very often indeed 
 Quite often 
 Not very often 
 Not at all 
 
14. I can enjoy a good book or 
radio or TV programme: 
 Often 
 Sometimes 
 Not often 
 Very seldom
Please ensure that you have responded to all items. Thank you 
HADS copyright © R.P. Snaith and A.S. Zigmond, 1983, 1992, 1994. 
Record form items originally published in Acta Psychiatrica Scandinavica 67, 361–70, copyright © Munksgaard 
International 
Publishers Ltd, Copenhagen, 1983. 
This edition first published in 1994 by nferNelson Publishing Company Ltd (now GL Assessment Ltd), 
389 Chiswick High Road, London W4 4AJ 
GL Assessment Ltd is part of the GL Education 
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Appendix S – Exploration of Normality and Parametric Assumptions 
 
Normal Distribution 
Several variables showed evidence of skewness and kurtosis and visual inspection 
suggested non-normal distributions (see figures S1, S3, S5, and S7). Kolmogorov-Smirnov test 
of normality was conducted on the distribution of adapted hospital and anxiety depression scale 
total (HADS-T), Repetitive negative thinking (RTQ-10), positive beliefs about worry (MCQ-
POS) and negative beliefs about the danger and uncontrollability of worry (MCQ-NEG) (see 
table S1). 
 
HADS-T [Statistic (77) = 0.141, p = 0.001], RTQ-10 [Statistic (77) = 0.101, p = 0.05], 
MCQ-POS [Statistic (77) = 0.240, p < 0.001], MCQ-NEG [Statistic (77) = .0.150, p < 0.001], 
were found to significantly deviate from the normal distribution. Therefore, the assumption of 
normally distributed data was not met. 
 
Outliers 
An examination of box plots revealed the presence of outliers on HADS-T 
Positive beliefs about worry (MCQ-POS) (see figures S2, S4, S6, S8). These were not extreme 
points and on closer inspection appeared to be valid responses so outliers were retained for use in 
the analyses. 
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Table S1 
 Tests of normality  
 
  
Tests of Normality 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
HADS total score adapted for 
MND (items removed) A11 & 
D8 & D10 
.141 77 .001 .932 77 .000 
MCQ positive beliefs 
subscale, items 1, 7, 10, 19, 
23, 28 
.240 77 .000 .766 77 .000 
MCQ negative beliefs about 
worry: 2,4,9,11,15,21 
.150 77 .000 .886 77 .000 
MCQ cognitive confidence: 
8,14,17,24,26,29 
.184 77 .000 .840 77 .000 
MCQ need for control: 
6,13,20,22,25,27 
.173 77 .000 .894 77 .000 
MCQ Cogntive self confidence 
3,5,12,16,18,30 
.101 77 .049 .969 77 .055 
RTQ-10 Total .101 77 .050 .954 77 .007 
a. Lilliefors Significance Correction 
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Figure S1. Histogram of HADS-T distribution  Figure S2. HADS-T boxplot 
 
 
 
 
 
Figure S3. Histogram to display PMCB   Figure S4. PMCB boxplot 
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Figure S5. Histogram to display NMCB  Figure S6. NMCB boxplot 
 
 
 
 
Figure S7. Histogram to display RTQ-10  Figure S8. RTQ-10 boxplot   
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Exploration of regression assumptions 
Multicollinearity 
To check variables for the presence of multicollinearity the correlation matrix was inspected to 
ensure no predictors correlated too highly with each other (r > 0.9). Tolerance values were all 
above 0.2 and variance inflation factors (VIFs) all below 10. The average VIF value was 1.15, 
close to 1. Eigenvalues has no large variance proportions on the same small eigenvalues.  
 
Assumption of independent errors 
Durbin-Watson value was 2.18, within expected range of 1 to 3.  
 
Extreme cases 
Casewise diagnostics did not identify any cases with standardised residuals outside of the range 
or -3 to 3. Cooks distance values were all below 1, therefore no cases have an undue influence on 
the model. All leverage values were within the expected boundary of three times the average 
leverage value. Malanchobis distance was scanned for values above 23.21 based upon the chi 
square distribution. One value exceeded this score (case 27 = 30.88) however was included given 
that there are no major problems with undue influence on the model. DFBeta, values all within 
the expected range (<1). 
 
Linearity and homoscedasticity 
Zresid vs Zpred plot indicated homoscedasticity and linearity. Partial plots indicated some slight 
funnelling of positive metacognitive beliefs and time since diagnosis. 
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Normal distribution  
On visual inspection data was normally distributed (see figures S9, S10, S11). 
 
Figure S9. Histogram to display HADS-T   Figure S10. P-Plot of HADS-T 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S11. HADS-T scatterplot 
